var title_f12_4_12352="Gastric carcinoids Endosc";
var content_f12_4_12352=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73158&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73158&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Type I gastric carcinoids",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 313px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic picture of the gastric corpus in a patient with pernicious anemia demonstrates multiple polypoid masses that were shown to be carcinoids, type I.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Atlas of Tumor Pathology (electronic fascicle), Third series, Fascicle 18, 1996, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12352=[""].join("\n");
var outline_f12_4_12352=null;
var title_f12_4_12353="Partial nail avulsion 2";
var content_f12_4_12353=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    Partial nail avulsion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 476px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12353=[""].join("\n");
var outline_f12_4_12353=null;
var title_f12_4_12354="CT bifrontal cerebral contusions";
var content_f12_4_12354=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F53951&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F53951&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Frontal cerebral contusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 442px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan of the brain depicting cerebral contusions. The basal frontal areas (as shown) are particularly susceptible.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: J Claude Hemphill III, MD and Nicholas Phan, MD, FRCSC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12354=[""].join("\n");
var outline_f12_4_12354=null;
var title_f12_4_12355="Patient information: Fragile X syndrome (The Basics)";
var content_f12_4_12355=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/87575\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/43/4787\">",
"         Crossed eyes (strabismus)",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/43/22194\">",
"          Male reproductive anatomy",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"           Female reproductive anatomy",
"          </a>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?11/32/11778\">",
"         Patient information: Attention deficit hyperactivity disorder (ADHD) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/37/38481\">",
"         Patient information: Autism (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?26/58/27553\">",
"         Patient information: Crossed eyes and lazy eye (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/47/38641\">",
"         Patient information: Learning disabilities (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/42/3746\">",
"         Patient information: Medicines for attention deficit hyperactivity disorder (ADHD) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/56/28546\">",
"         Patient information: Seizures (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/14/13538\">",
"         Patient information: Tremor (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?40/46/41699\">",
"         Patient information: Autism spectrum disorders (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/26/419\">",
"         Patient information: Seizures in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/53/35668\">",
"         Patient information: Treatment of attention deficit hyperactivity disorder in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/6/34913\">",
"         Patient information: Tremor (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Fragile X syndrome (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H612644485\">",
"      <span class=\"h1\">",
"       What is fragile X syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Fragile X syndrome is a life-long condition that a person is born with. It causes learning and behavior problems, and certain body features. It can also cause certain medical problems. Fragile X syndrome happens more often in boys than girls.",
"     </p>",
"     <p>",
"      Fragile X syndrome is caused by a problem with a chromosome called the &ldquo;X&rdquo; chromosome. Chromosomes are tiny parts of cells that carry the plans that make our bodies the way they are.",
"     </p>",
"     <p>",
"      Doctors do not know why some babies are born with fragile X syndrome.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H612644500\">",
"      <span class=\"h1\">",
"       What are the symptoms of fragile X syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms can be different in different people. But in general, people with fragile X syndrome have the following body features:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A head that is bigger than normal (in children)",
"       </li>",
"       <li>",
"        Crossed eyes, which is when the eyes don&rsquo;t line up or look in the same direction (",
"        <a class=\"graphic graphic_figure graphicRef74106 \" href=\"UTD.htm?4/43/4787\">",
"         figure 1",
"        </a>",
"        )",
"       </li>",
"       <li>",
"        Big ears and eyes that look &ldquo;sunken in&rdquo;",
"       </li>",
"       <li>",
"        Loose joints, such as in the thumbs, fingers, or wrists",
"       </li>",
"       <li>",
"        Flat feet",
"       </li>",
"       <li>",
"        Testicles that are bigger than normal (in male teens and adults) (",
"        <a class=\"graphic graphic_figure graphicRef68075 \" href=\"UTD.htm?21/43/22194\">",
"         figure 2",
"        </a>",
"        )",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Fragile X syndrome causes learning and behavior problems. Babies with fragile X syndrome can take longer to sit, walk, or talk. Children with fragile X syndrome can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Have trouble with problem solving and organization",
"       </li>",
"       <li>",
"        Have problems with language and speaking",
"       </li>",
"       <li>",
"        Have trouble sitting still, paying attention, or making good decisions",
"       </li>",
"       <li>",
"        Feel very worried or sad",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Fragile X syndrome also sometimes causes certain medical problems. These include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Seizures, which are waves of abnormal electrical activity in the brain that can make people pass out or move or behave strangely",
"       </li>",
"       <li>",
"        Trouble with the way a woman&rsquo;s ovaries (reproductive organs) work (",
"        <a class=\"graphic graphic_figure graphicRef80271 \" href=\"UTD.htm?14/52/15171\">",
"         figure 3",
"        </a>",
"        )",
"       </li>",
"       <li>",
"        A tremor, which is when the hand shakes",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H612644515\">",
"      <span class=\"h1\">",
"       Is there a test for fragile X syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. To check for fragile X syndrome, your doctor or nurse will do an exam, ask about symptoms, and ask whether other family members have the condition. He or she will also order a blood test to check for the abnormal gene.",
"     </p>",
"     <p>",
"      Children and adults can be tested for fragile X syndrome if they have symptoms of the condition. People can also be tested for fragile X syndrome if they have a family member with the condition. Pregnant women might also choose to test their unborn baby for the condition, if it runs in the family.",
"     </p>",
"     <p>",
"      Children who are diagnosed with fragile X syndrome will need further tests. These include tests to check their thinking, learning, and behavior.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H612644530\">",
"      <span class=\"h1\">",
"       How is fragile X syndrome treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends on a person&rsquo;s symptoms and individual situation. It usually involves 1 or more of the following:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A school plan &ndash; Depending on your child&rsquo;s learning problems, the school will make a learning plan for your child.",
"       </li>",
"       <li>",
"        Behavior therapy &ndash; This involves making changes at home or at school to help with your child&rsquo;s behavior.",
"       </li>",
"       <li>",
"        Speech, language, physical, or occupational therapy &ndash; Specialists can help with your child&rsquo;s language and the way he or she moves or does everyday activities.",
"       </li>",
"       <li>",
"        Medicines &ndash; The doctor might recommend that your child take medicine. Some medicines help children sit still and pay attention. Others help when children feel very worried or sad. Children who have seizures are treated with medicines called anti-seizure medicines.",
"       </li>",
"       <li>",
"        Regular follow-ups with the doctor &ndash; The doctor will see your child on a regular basis. That way, he or she can do exams and tests to monitor your child for medical problems that can happen in children with fragile X syndrome.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H612644545\">",
"      <span class=\"h1\">",
"       Should other family members be tested for fragile X syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you or your child is diagnosed with fragile X syndrome, let your family members know. They should talk with their doctor about getting tested for the condition.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H612644560\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you want to get pregnant, talk with your doctor or nurse before you start trying. He or she will probably recommend that you speak with a genetic counselor (a person who specializes in genetic conditions).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H612644575\">",
"      <span class=\"h1\">",
"       How can I learn more about fragile X syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To learn more, talk with your child&rsquo;s doctor or nurse. The National Fragile X Foundation also has information. Their Web site is",
"      <a class=\"external\" href=\"file://www.fragilex.org/\">",
"       www.fragilex.org",
"      </a>",
"      .",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H612644590\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?26/58/27553?source=see_link\">",
"       Patient information: Crossed eyes and lazy eye (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/47/38641?source=see_link\">",
"       Patient information: Learning disabilities (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/32/11778?source=see_link\">",
"       Patient information: Attention deficit hyperactivity disorder (ADHD) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/37/38481?source=see_link\">",
"       Patient information: Autism (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/56/28546?source=see_link\">",
"       Patient information: Seizures (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/14/13538?source=see_link\">",
"       Patient information: Tremor (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/42/3746?source=see_link\">",
"       Patient information: Medicines for attention deficit hyperactivity disorder (ADHD) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/46/41699?source=see_link\">",
"       Patient information: Autism spectrum disorders (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/26/419?source=see_link\">",
"       Patient information: Seizures in children (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/6/34913?source=see_link\">",
"       Patient information: Tremor (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/53/35668?source=see_link\">",
"       Patient information: Treatment of attention deficit hyperactivity disorder in children (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?12/4/12355?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 87575 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-09F22AFDA5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12355=[""].join("\n");
var outline_f12_4_12355=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H612644485\">",
"      What is fragile X syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H612644500\">",
"      What are the symptoms of fragile X syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H612644515\">",
"      Is there a test for fragile X syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H612644530\">",
"      How is fragile X syndrome treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H612644545\">",
"      Should other family members be tested for fragile X syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H612644560\">",
"      What if I want to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H612644575\">",
"      How can I learn more about fragile X syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H612644590\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/87575\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/43/4787\">",
"      Crossed eyes (strabismus)",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/43/22194\">",
"       Male reproductive anatomy",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"        Female reproductive anatomy",
"       </a>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/32/11778?source=related_link\">",
"      Patient information: Attention deficit hyperactivity disorder (ADHD) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/37/38481?source=related_link\">",
"      Patient information: Autism (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/46/41699?source=related_link\">",
"      Patient information: Autism spectrum disorders (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?26/58/27553?source=related_link\">",
"      Patient information: Crossed eyes and lazy eye (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/47/38641?source=related_link\">",
"      Patient information: Learning disabilities (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/42/3746?source=related_link\">",
"      Patient information: Medicines for attention deficit hyperactivity disorder (ADHD) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/56/28546?source=related_link\">",
"      Patient information: Seizures (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/26/419?source=related_link\">",
"      Patient information: Seizures in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/53/35668?source=related_link\">",
"      Patient information: Treatment of attention deficit hyperactivity disorder in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/6/34913?source=related_link\">",
"      Patient information: Tremor (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/14/13538?source=related_link\">",
"      Patient information: Tremor (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_4_12356="Sipuleucel-T: Patient drug information";
var content_f12_4_12356=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Sipuleucel-T: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/18/12581?source=see_link\">",
"     see \"Sipuleucel-T: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F10170443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Provenge&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10182337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692030",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat prostate cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10182336\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2743340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to sipuleucel-T or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10182341\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697231",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had a stroke, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10182464\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating. You may be given drugs before this shot to avoid these signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698628",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697879",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals and good mouth care may help. Older children may suck hard, sugar-free candy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697883",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Back pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10182343\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699024",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699037",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle or joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10182339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694377",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Acetaminophen and diphenhydramine may be given before this drug to lower fever and chills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2743342",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You will need to have a cell collection called leukopheresis about 3 days before you get this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10182340\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10182465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10182424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12305 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-201.65.114.212-1237D62C13-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12356=[""].join("\n");
var outline_f12_4_12356=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10170443\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10182337\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10182336\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10182341\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10182464\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10182343\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10182339\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10182340\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10182465\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10182424\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/18/12581?source=related_link\">",
"      Sipuleucel-T: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_4_12357="Sexual problems in women";
var content_f12_4_12357=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Sexual problems in women (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?12/4/12357/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12357/contributors\" id=\"au2740\">",
"       Jan L Shifren, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?12/4/12357/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12357/contributors\" id=\"se4464\">",
"       Robert L Barbieri, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?12/4/12357/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12357/contributors\" id=\"de1930\">",
"       Sandy J Falk, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?12/4/12357?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      SEXUAL PROBLEMS OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Sexual problems are common and can occur in women of any age. In the United States, approximately 40 percent of women have sexual concerns and 12 percent report distressing sexual problems [",
"     <a class=\"abstract\" href=\"UTD.htm?12/4/12357/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     Sexual dysfunction is a term used to describe difficulties in libido (sex drive), arousal, orgasm, or pain with sex that is bothersome to an individual. Sexual dysfunction may be a lifelong problem or acquired later in life after a period of having no difficulties with sex.",
"    </p>",
"    <p>",
"     Women are most likely to be satisfied with their sex lives if they are physically and psychologically healthy and have a good relationship with their partner. Although a host of changes in hormones, blood vessels, the brain, and vaginal area can affect a woman's sexuality, relationship difficulties and poor physical or psychological well-being are the most common causes of sexual problems.",
"    </p>",
"    <p>",
"     This article will discuss causes as well as treatments that are available to help women who have problems with sex. Sexual problems in men are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/33/29205?source=see_link\">",
"      \"Patient information: Sexual problems in men (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      SEXUAL PROBLEMS TERMINOLOGY",
"     </span>",
"    </p>",
"    <p>",
"     It is important to know the definitions of several terms used to describe the sexual response to understand related sexual problems.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Desire (libido)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Libido, or sex drive, is the desire to have sexual activity, and often involves sexual thoughts, images, and wishes. Desire may occur spontaneously or in response to a partner, thoughts, or images. Spontaneous desire is more common in new relationships while response to a partner's desire is more typical of long-term relationships.",
"    </p>",
"    <p>",
"     Sexual desire is not essential to have a satisfactory sex life. In other words, a woman who does not think about or initiate sex does not necessarily have a problem.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Arousal (excitement)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Arousal is a sense of sexual pleasure, often accompanied by an increase in blood flow to the genitals and an increased heart rate, blood pressure, and rate of breathing.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Orgasm",
"     </span>",
"     &nbsp;&mdash;&nbsp;Orgasm is defined as a peaking of sexual pleasure and release of sexual tension, usually with contractions of the muscles in the genital area and reproductive organs. A woman who never or rarely experiences an orgasm may still experience pleasure with sex and does not have a sexual problem unless this is bothersome to her.",
"    </p>",
"    <p>",
"     Although desire, arousal, and orgasm describe the typical sexual response, the goal of sexual activity is satisfaction, which may or may not involve all aspects of the sexual response cycle (desire, arousal, orgasm).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      RISK FACTORS FOR SEXUAL PROBLEMS",
"     </span>",
"    </p>",
"    <p>",
"     There are a number of risk factors that may contribute to sexual problems in women. A risk factor is not necessarily the cause of a problem, but rather something that makes the problem more likely. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25258?source=see_link\">",
"      \"Sexual dysfunction in women: Epidemiology, risk factors, and evaluation\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Personal well-being",
"     </span>",
"     &nbsp;&mdash;&nbsp;A woman's sense of personal well being is important to sexual interest and activity. A woman who does not feel her best physically or emotionally may experience a decrease in sexual interest or response.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Relationship issues",
"     </span>",
"     &nbsp;&mdash;&nbsp;An emotionally healthy relationship with current and past sexual partners is the most important factor in sexual satisfaction. Stress or conflict between a woman and her partner, and current or past emotional, physical, or sexual abuse often influence a women's sexual satisfaction. In addition, even good relationships can become less exciting sexually over time.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Male sexual problems",
"     </span>",
"     &nbsp;&mdash;&nbsp;For women with a male sexual partner, midlife changes in the partner can affect her sexual response. Male sexual problems, (erectile dysfunction, diminished libido, or abnormal ejaculation), can occur at any time, but become more common with advancing age. In addition, women tend to live longer than men, resulting in a shortage of healthy, sexually functional partners for older women.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Gynecologic issues",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h3\">",
"      Childbirth",
"     </span>",
"     &nbsp;&mdash;&nbsp;After childbirth, physical recovery and breastfeeding, as well as fatigue and the demands of parenting, often decrease sexual desire. Low estrogen levels after delivery and local injury to the genital area at delivery may result in pain during intercourse. In most cases, these issues improve with time.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h3\">",
"      Menopause",
"     </span>",
"     &nbsp;&mdash;&nbsp;Estrogen is a female hormone produced by the ovaries. During the several years before menopause, estrogen levels begin to fluctuate. After menopause, estrogen levels decline dramatically. This may lead to changes in a woman's libido and ability to become aroused. Hot flashes, night sweats, sleep disruption, and fatigue also may contribute to sexual problems. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/4/32835?source=see_link\">",
"      \"Patient information: Postmenopausal hormone therapy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     In addition, some women experience vaginal narrowing, dryness, and a decrease in elasticity of the vaginal wall after menopause, especially if intercourse is infrequent, which can lead to discomfort or pain during sex. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/23/7537?source=see_link\">",
"      \"Patient information: Vaginal dryness (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Hysterectomy",
"     </span>",
"     &nbsp;&mdash;&nbsp;In general, hysterectomy does not cause sexual dysfunction. Most studies actually show in improvement in sexual function after hysterectomy, likely due to an improvement in symptoms that interfere with sex, such as heavy bleeding. Removal of the cervix at the time of hysterectomy also has no negative effect on sexuality. Removal of the ovaries at the time of hysterectomy, typically done to decrease the risk of ovarian cancer, reduces estrogen and androgen levels, which may impact sexual function for some women. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/48/34564?source=see_link\">",
"      \"Patient information: Vaginal hysterectomy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Vaginal or pelvic pain",
"     </span>",
"     &nbsp;&mdash;&nbsp;Women who have vaginal or pelvic pain often have difficulty with sexual activity. Pain may lead to fear of further pain during sex and can diminish lubrication and cause involuntary tightening of the vaginal muscles, causing further pain.",
"    </p>",
"    <p>",
"     Pain may be caused by endometriosis, prior surgeries, infection, or scar tissue. In postmenopausal women, a lack of estrogen often causes discomfort with intercourse. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/55/32627?source=see_link\">",
"      \"Patient information: Chronic pelvic pain in women (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Bladder and pelvic support issues",
"     </span>",
"     &nbsp;&mdash;&nbsp;Changes in the bladder or loss of pelvic support (pelvic organ prolapse) can lead to loss of urine (incontinence) or sensations of vaginal pressure. These symptoms may interfere with sexual desire or activity in some women. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/16/9474?source=see_link\">",
"      \"Patient information: Urinary incontinence in women (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Medical issues",
"     </span>",
"     &nbsp;&mdash;&nbsp;Almost any serious or chronic medical problem can impact a woman's sexual desire and responsiveness. Problems such as coronary artery disease and arthritis can affect a woman's physical ability to have sex. Indeed, arthritis has been identified in some studies as a common cause of sexual inactivity in the United States.",
"    </p>",
"    <p>",
"     Women with cancer can experience discomfort and fatigue, due to both the disease and its treatments, which impacts sexual function. Changes in body image, especially after surgery on the breasts or other intimate areas, can contribute to sexual problems in women with cancer.",
"    </p>",
"    <p>",
"     Other conditions such as Parkinson disease, complications of diabetes, or alcohol and drug abuse can impair arousal and ability to experience orgasm.",
"    </p>",
"    <p>",
"     Psychiatric or emotional problems may also impact sexual function, either due to the disease itself or its treatment (see below). Depression is one of the most common causes of decreased libido and other sexual disorders in women.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Both prescription and nonprescription medications can alter sexual desire, arousal, and orgasm. This may include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Beta blockers (used to treat high blood pressure)",
"      </li>",
"      <li>",
"       Many antidepressants (especially selective serotonin reuptake inhibitors)",
"      </li>",
"      <li>",
"       Some antipsychotic medications (used for psychiatric problems as well as sleep disorders and other conditions)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     It is not clear if hormonal medications, such as birth control pills and menopausal hormone therapy, affect sexuality. Studies have shown mixed results, with some studies showing that hormonal medications have no effect while others showing worsening or improvement of sexual problems in women who take hormonal medications.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;Certain surgeries can affect a woman's sexual response. In particular, surgeries of the breast or the reproductive organs can change how a woman feels about her body, particularly if there is an underlying diagnosis such as cancer that led to the surgery.",
"    </p>",
"    <p>",
"     Hysterectomy, with or without removal of the cervix should not negatively impact sexual function once healing is complete. However, some women experience sexual problems after both ovaries are removed, possibly due to decreased estrogen",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     androgen levels. (See",
"     <a class=\"local\" href=\"#H13\">",
"      'Hysterectomy'",
"     </a>",
"     above.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      TREATMENT OF SEXUAL PROBLEMS",
"     </span>",
"    </p>",
"    <p>",
"     A number of treatments are available for women with sexual problems. In many cases, a combination of treatments is most effective. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34985?source=see_link\">",
"      \"Sexual dysfunction in women: Management\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Manage stress and relationship issues",
"     </span>",
"     &nbsp;&mdash;&nbsp;Stress, fatigue, lack of privacy, personal values, and religious beliefs can all impact sexuality. Conflict in a relationship and difficulties with communication also are a significant cause of decreased sexual desire and response for women. Working with a professional counselor or sex therapist can help individuals and couples reduce stress and strengthen their relationships.",
"    </p>",
"    <p>",
"     Most couples have better sex while on vacation, demonstrating the importance of reducing stress and fatigue to improve sexual satisfaction. Couples who have more fun together outside of the bedroom typically have more fun in the bedroom, so establishing a regular \"date night\" and increasing the frequency of special outings and vacations is an effective treatment for many sexual problems.",
"    </p>",
"    <p>",
"     Counseling, books, and web sites help couples communicate better about their sexual needs and differences, understand the causes of their difficulties, and provide treatment suggestions. If there are underlying physical problems (eg, pelvic pain), getting these problems under control also may help to improve sexual difficulties. (See",
"     <a class=\"local\" href=\"#H32\">",
"      'Where to get more information'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Treat vaginal dryness",
"     </span>",
"     &nbsp;&mdash;&nbsp;Women with vaginal dryness or discomfort may benefit from using a long-acting non-hormonal vaginal moisturizer several times weekly. Lubricant use with intercourse also increases comfort and pleasure. Postmenopausal women generally will benefit for use of low dose vaginal estrogen therapy. Treatment of vaginal dryness is discussed in detail in a separate topic. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/23/7537?source=see_link\">",
"      \"Patient information: Vaginal dryness (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h2\">",
"      Treat painful sex",
"     </span>",
"     &nbsp;&mdash;&nbsp;Many women who have pain with sex have tight and tender muscles and connective tissue in the pelvis, lower belly, thighs, groin, and buttocks.",
"    </p>",
"    <p>",
"     Pelvic floor physical therapy (PT) can help to decrease tightness in these muscles. This type of PT is quite different from physical therapy intended to treat a knee injury or back pain, which usually works to increase muscle strength.",
"    </p>",
"    <p>",
"     With pelvic floor PT, the physical therapist works on your body to manually \"release\" the tightness and tender points of the connective tissues and muscles. This includes the muscles and tissues of the vagina or rectum, abdomen, hips, thighs, and lower back. Physical therapists who perform this type of PT must be specially trained in pelvic soft tissue manipulation and rehabilitation.",
"    </p>",
"    <p>",
"     Often painful sex is due to involuntary tightening of the muscles of the vaginal wall, called &ldquo;vaginismus.&rdquo; This is best treated by purchasing a set of vaginal dilators and gently stretching the vagina over several months. A well-lubricated dilator of the appropriate size should be placed in the vagina several times for 5 to 10 minutes nightly. The size of the dilator is gradually increased until intercourse is once again comfortable. These exercises are best guided by a gynecologist or pelvic floor physical therapist.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Deal with sexual side effects of medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;If you have sexual side effects from a medicine, speak with your healthcare provider about options for reducing or eliminating this problem.",
"    </p>",
"    <p>",
"     Options for women who have side effects from an antidepressant medication include trying a reduced dose or change in type of antidepressant medication. Bupropion (Wellbutrin&reg;), Nefazodone (Serzone&reg;), mirtazapine (Remeron&reg;), or duloxetine (Cymbalta&reg;) are antidepressant medications that have few or no sexual side effects, and can sometimes be used in addition to or in place of your current medication. Talk to your healthcare provider before making any changes in your medications.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Carefully consider androgens",
"     </span>",
"     &nbsp;&mdash;&nbsp;Androgens, such as testosterone, are sex hormones that are produced in the testes and adrenal glands in men and the ovaries and adrenal glands in women. In men, androgens are responsible for producing typical male characteristics, such as facial hair, as well as feelings of desire and arousal.",
"    </p>",
"    <p>",
"     However, the role of androgens in female sexuality is not clear. Androgen levels decline with aging, so all postmenopausal women have low blood levels of androgens. Studies of postmenopausal women with low sexual desire associated with distress and no other identifiable cause have shown that testosterone treatment may result in small but significant improvements in sexual desire and response. Although studies of a testosterone patch showed benefit, studies of a testosterone gel showed no benefit compared with a placebo gel. No androgen products are approved for the treatment of women with sexual dysfunction in the United States due to the lack of data regarding long term safety.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h3\">",
"      Testosterone",
"     </span>",
"     &nbsp;&mdash;&nbsp;Testosterone products are sometimes used \"off-label\" to treat sexual problems in women. These products include testosterone skin patches, gels, creams or ointments, pills, implants, and injections. Testosterone doses provided by these formulations are often too high for women, increasing the likelihood of side effects. Testosterone is not recommended for premenopausal women.",
"    </p>",
"    <p>",
"     Testosterone skin patches designed for women are available in Europe for postmenopausal women with decreased sexual desire. Studies of the testosterone patch have been completed in the United States, although further study of long-term safety will be required before these products are approved.",
"    </p>",
"    <p>",
"     Women who are considering use of testosterone should discuss the possible side effects of this treatment with their healthcare provider. (See",
"     <a class=\"local\" href=\"#H27\">",
"      'Androgen side effects'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H26\">",
"     <span class=\"h3\">",
"      DHEA",
"     </span>",
"     &nbsp;&mdash;&nbsp;Studies on the use of DHEA (dehydroepiandrosterone), available as a nutritional supplement in the United States, have shown that DHEA can improve sexual interest and satisfaction in some women whose adrenal glands no longer function (adrenal insufficiency). (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/0/9220?source=see_link\">",
"      \"Patient information: Adrenal insufficiency (Addison's disease) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     However, DHEA is not proven to be safe or effective for other women, and it is not generally recommended. In addition, DHEA is produced as a nutritional supplement, and the amount of hormone may vary from one pill or bottle to another.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27\">",
"     <span class=\"h3\">",
"      Androgen side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Side effects of testosterone treatment are a concern; androgens can increase hair growth on the body and face and cause scalp hair loss, oily skin, acne, irreversible deepening of the voice, liver problems, and high cholesterol levels. In addition, because testosterone is converted to estrogen in a woman's body, there may be an increased risk of breast cancer, coronary heart disease, leg and lung clots, and stroke. Women who take androgens should be monitored closely for side effects. They also must be aware that long-term safety is unknown.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H28\">",
"     <span class=\"h2\">",
"      Erectile dysfunction medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Medications commonly used for men with erectile problems, including sildenafil (Viagra&reg;), tadalafil (Cialis&reg;), or vardenafil (Levitra&reg;), have not been shown to improve sexual function in women and are not usually recommended. The only exception to this is in women who take certain antidepressant medications who have difficulty achieving orgasm and who cannot switch to another antidepressant medication; an erectile dysfunction medication may be helpful in this situation.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H29\">",
"     <span class=\"h2\">",
"      Treatments that are unproven",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H30\">",
"     <span class=\"h3\">",
"      Herbal therapies",
"     </span>",
"     &nbsp;&mdash;&nbsp;Many women are interested in trying over-the-counter herbal supplements, which are advertised to increase sexual desire and pleasure. More studies are needed to assess whether herbal therapies are safe and effective. Some herbal supplements may improve sexual function, but no more than would a placebo. The production of herbs is not regulated by the government, and it is not always possible to know that an herbal product contains the type and quantity of ingredient that the label indicates, or that it is free of potentially dangerous additives. People who wish to use herbal therapies are urged to do so with caution.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H31\">",
"     <span class=\"h3\">",
"      Surgical treatments",
"     </span>",
"     &nbsp;&mdash;&nbsp;Surgery is very rarely necessary to make the vagina \"better\" for sex. Women with abnormalities of the vagina, who have had female circumcision (also known as female genital mutilation), and those with traumatic injuries from childbirth are a few groups that may benefit from careful surgical treatment.",
"    </p>",
"    <p>",
"     All women should be wary of advertisements for \"vaginal rejuvenation surgery\"; these procedures can be costly and painful, may result in painful intercourse, and are permanent, and are unlikely to improve a woman's or her partner's sexual enjoyment.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H32\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3498690149\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27351291\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/12/23747?source=see_link\">",
"      Patient information: Uterine cancer (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/27/40370?source=see_link\">",
"      Patient information: Menopause (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/17/11538?source=see_link\">",
"      Patient information: Sex problems in women (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/42/21156?source=see_link\">",
"      Patient information: Recovery after coronary artery bypass graft surgery (CABG) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/2/13346?source=see_link\">",
"      Patient information: Atrophic vaginitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?26/53/27475?source=see_link\">",
"      Patient information: Paraplegia and quadriplegia (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/60/43970?source=see_link\">",
"      Patient information: Dyspareunia (painful sex) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/36/19009?source=see_link\">",
"      Patient information: Vaginismus (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/2/12322?source=see_link\">",
"      Patient information: Bartholin&rsquo;s gland cyst (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/20/16706?source=see_link\">",
"      Patient information: Sex as you get older (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/33/36370?source=see_link\">",
"      Patient information: Vulvar pain (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27351306\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/33/29205?source=see_link\">",
"      Patient information: Sexual problems in men (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/4/32835?source=see_link\">",
"      Patient information: Postmenopausal hormone therapy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/23/7537?source=see_link\">",
"      Patient information: Vaginal dryness (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/48/34564?source=see_link\">",
"      Patient information: Vaginal hysterectomy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/55/32627?source=see_link\">",
"      Patient information: Chronic pelvic pain in women (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/16/9474?source=see_link\">",
"      Patient information: Urinary incontinence in women (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/0/9220?source=see_link\">",
"      Patient information: Adrenal insufficiency (Addison's disease) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H33\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=see_link\">",
"      Approach to the woman with sexual pain",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23128?source=see_link\">",
"      Differential diagnosis of sexual pain in women",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37642?source=see_link\">",
"      Chronic complications of spinal cord injury",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33800?source=see_link\">",
"      Clinical manifestations of adrenal insufficiency in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/7/36985?source=see_link\">",
"      Comorbid problems associated with multiple sclerosis in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32533?source=see_link\">",
"      Evaluation of male sexual dysfunction",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42696?source=see_link\">",
"      Overview of male sexual dysfunction",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2039?source=see_link\">",
"      Sexual dysfunction associated with selective serotonin reuptake inhibitor (SSRI) antidepressants",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25258?source=see_link\">",
"      Sexual dysfunction in women: Epidemiology, risk factors, and evaluation",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42904?source=see_link\">",
"      The sexual history and approach to the patient with sexual dysfunction",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/36/30282?source=see_link\">",
"      Treatment of male sexual dysfunction",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34985?source=see_link\">",
"      Sexual dysfunction in women: Management",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Association of Sex Educators, Counselors, and Therapists",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.aasect.org/\">",
"      www.aasect.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Association for Marriage and Family Therapy",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.aamft.org\">",
"      www.aamft.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Sexuality Information and Education Council of the United States",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.siecus.org/\">",
"      www.siecus.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Society for Sex Therapy and Research",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.sstarnet.org/\">",
"      www.sstarnet.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The Women's Sexual Health Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.twshf.org/\">",
"      www.twshf.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The North American Menopause Society (module on Sexual Health and Menopause)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.menopause.org/\">",
"      www.menopause.org",
"     </a>",
"     )",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H34\">",
"     <span class=\"h2\">",
"      Patient Support",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are a number of online forums where patients can find information and support from other people with similar conditions.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <a class=\"external\" href=\"file://about.com/\">",
"        About.com",
"       </a>",
"       Sexuality Forum",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://sexuality.about.com/forum\">",
"      file://sexuality.about.com/forum",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?12/4/12357/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 27, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?12/4/12357?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12357/abstract/1\">",
"      Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008; 112:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12357/abstract/2\">",
"      Basson R. Clinical practice. Sexual desire and arousal disorders in women. N Engl J Med 2006; 354:1497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12357/abstract/3\">",
"      Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 2006; 13:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12357/abstract/4\">",
"      Segraves RT, Clayton A, Croft H, et al. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004; 24:339.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f12_4_12357=[""].join("\n");
var outline_f12_4_12357=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           SEXUAL PROBLEMS OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           SEXUAL PROBLEMS TERMINOLOGY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           RISK FACTORS FOR SEXUAL PROBLEMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           TREATMENT OF SEXUAL PROBLEMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H32\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f12_4_12358="Pulmonary arteriovenous malformations: Treatment";
var content_f12_4_12358=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pulmonary arteriovenous malformations: Treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12358/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12358/contributors\">",
"     James R Gossage, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12358/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12358/contributors\">",
"     Jess Mandel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12358/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12358/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/4/12358/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H22766827\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary arteriovenous malformations (PAVM) are abnormal communications between pulmonary veins and arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/1\">",
"     1",
"    </a>",
"    ]. Alternative names include pulmonary arteriovenous fistulae, pulmonary arteriovenous aneurysms, cavernous angiomas of the lung, and pulmonary telangiectases [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/2\">",
"     2",
"    </a>",
"    ]. PAVM are uncommon, but they are an important consideration in the differential diagnosis of common pulmonary problems, including hypoxemia, pulmonary nodules, and hemoptysis.",
"   </p>",
"   <p>",
"    The treatment of PAVM is reviewed here. The epidemiology, etiology, pathology, clinical features, and diagnosis of PAVM are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27656?source=see_link\">",
"     \"Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32263?source=see_link\">",
"     \"Pulmonary arteriovenous malformations: Diagnostic evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22767252\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mortality, morbidity, and growth of PAVM have been studied, but remain incompletely defined:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mortality: Most deaths attributable to PAVM are caused by stroke, cerebral abscess, hemoptysis, or hemothorax [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/3-6\">",
"       3-6",
"      </a>",
"      ]. The mortality rate due to PAVM is uncertain because most case series have poorly described the duration that the patients were followed.",
"     </li>",
"     <li>",
"      Morbidity: Morbidity associated with PAVM is significant. A pooled analysis of three studies that followed patients with untreated PAVM for variable periods of time (mean of 5 to 6 years per study, with a range of 1 to 13 years) found that the risk of clinical stroke was 13 percent, brain abscess was 11 percent, and combined morbidity and mortality was 22 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/3-5\">",
"       3-5",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The risk of neurologic complications increases with the number of PAVM and the patient&rsquo;s age [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. This was illustrated by two studies. In the first study, radiologic evidence of cerebral infarction was found in 32 percent of patients with single and 60 percent of patients with multiple PAVM [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/8\">",
"       8",
"      </a>",
"      ]. In the second study of 71 patients with HHT and PAVM, embolic neurologic complications (ie, stroke, transient ischemic attack, or cerebral abscess) occurred in 10 percent of patients less than 30 years old and 45 percent of older patients [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Growth: Most PAVM remain stable in size. However, approximately 25 percent of PAVM will enlarge gradually, usually at a rate of 0.3 to 2",
"      <span class=\"nowrap\">",
"       mm/year",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/4,9\">",
"       4,9",
"      </a>",
"      ]. PAVM do not spontaneously resolve.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1575941\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for the treatment of PAVM include progressive enlargement, paradoxic embolization, or symptomatic hypoxemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, at least one consensus statement recommends treatment of PAVM with feeding vessels that are 2 to 3 mm or larger [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/11\">",
"     11",
"    </a>",
"    ]. This is based upon several reports of an increased incidence of neurologic complications in patients who have PAVM &gt;2 cm in diameter with feeding vessels that are &gt;3 mm [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/10,12-14\">",
"     10,12-14",
"    </a>",
"    ]. We adhere to this consensus recommendation, referring patients for pulmonary angiography if they have PAVM with feeding arteries greater than 2 to 3 mm on chest CT. At the time of pulmonary angiography, PAVM with feeding arteries that are 3 mm or greater are targeted for embolization and smaller PAVM are embolized if technically possible due to their propensity to enlarge over time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576056\">",
"    <span class=\"h1\">",
"     THERAPIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22767266\">",
"    <span class=\"h2\">",
"     Embolization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Embolization therapy (ie, embolotherapy) refers to the angiographic occlusion of the feeding arteries to a PAVM. It begins with diagnostic conventional pulmonary angiography to fully characterize the PAVM, followed by catheter-directed placement of embolic material into the feeding artery of the PAVM until blood flow ceases [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/15\">",
"     15",
"    </a>",
"    ]. Diagnostic angiography is usually performed in the same session as embolization therapy. Multiple PAVM may be embolized during a single session, and additional sessions may be performed after a hiatus of one to two weeks if additional PAVM remain perfused.",
"   </p>",
"   <p>",
"    Diffuse PAVM are a unique management challenge. Any discrete PAVM with feeding arteries greater than 2 to 3 mm should be embolized. This often has little effect on the severe hypoxemia that accompanies PAVM because shunting through the other PAVM persists [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/16\">",
"     16",
"    </a>",
"    ]; however, the goal is to reduce the severe complications associated with PAVM, such as stroke or cerebral abscess. Embolizing the pertinent segmental arteries from the periphery toward the center may improve symptoms in highly symptomatic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Metallic coils (steel, titanium, or platinum) or detachable balloons are the usual embolic materials. When coils are used, optimal results are obtained when at least two coils are placed as close as possible to the AVM sac. Generally speaking, coils should be 2 mm wider than the feeding artery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/12,18\">",
"     12,18",
"    </a>",
"    ]. If steel coils are used, MRI of the brain (in order to screen for brain AVM in HHT patients) should be deferred for at least 6 weeks to allow the coils to fibrose into position, thereby minimizing their chance of movement during the MRI. An advantage of using detachable balloons rather than steel coils is that the balloons can be deflated and repositioned if necessary.",
"   </p>",
"   <p>",
"    Alternative embolic materials include polyvinyl alcohol, wool coils, and Amplatzer vascular plugs. Amplatzer plugs are relatively new. In one study, Amplatzer plugs were used to successfully occlude 120 out of 161 PAVM (75 percent) in 69 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/19\">",
"     19",
"    </a>",
"    ]. There was a low incidence of complications and follow-up showed no instance of reperfusion, although the number of patients was small and the duration of follow-up short. Potential benefits of the Amplatzer plugs over conventional coils include more rapid occlusion of PAVM, a reduced procedure time, the ability to occlude more PAVM in a single session, occlusion of feeding vessels with shorter necks, theoretical reduction of paradoxical thrombus embolization during the procedure, and a potentially lower incidence of later reperfusion.",
"   </p>",
"   <p>",
"    Regarding the short-term outcomes of embolization, the procedural success rate is over 98 percent according to case series [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. This results in immediate and striking clinical benefits [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/22-25\">",
"     22-25",
"    </a>",
"    ], as demonstrated by a case series of 39 patients with bilateral PAVM who were followed for a mean of 43 months [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/22\">",
"     22",
"    </a>",
"    ]. Embolization was completely or partially successful radiographically in 97 percent of patients and there was improvement in dyspnea (in 80 percent of patients), NYHA functional class, and arterial oxygen tension (PaO2).",
"   </p>",
"   <p>",
"    There have been no reports of procedural mortality from embolization [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. The most common post-procedural complication is self-limited pleuritic chest pain in 5 to 13 percent of patients. Other procedural complications are infrequent with little or no long-term sequelae, including stroke (&lt;0.5 percent of patients), transient ischemic attaches (1 percent), transient air embolization (5 percent), radiographic pulmonary infarction (3 percent), deep venous thrombosis secondary to the angiography catheter (1.5 percent), distal migration of the detachable balloon (1 percent), reflux of the embolization coil, and arterial wall damage with potential perforation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Pleuritic chest pain usually responds to a short course of non-steroidal inflammatory agents, but occasionally a course of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    is necessary for more protracted pain.",
"   </p>",
"   <p>",
"    Regarding the long-term outcomes after embolization, few studies have reported on the persistence of symptomatic and physiological improvement. Instead, most have focused on prevention of the morbidities associated with PAVM [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/21\">",
"     21",
"    </a>",
"    ]. In one case series with a variable duration of follow-up (usually around five years), stroke",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cerebral abscess occurred in only 2 percent of patients and most of those events occurred in patients with large PAVM [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/13\">",
"     13",
"    </a>",
"    ]. Recanalization of occluded PAVM, development of new PAVM, and growth of new feeding arteries to occluded PAVM occurred in a few cases.",
"   </p>",
"   <p>",
"    There are few long-term complications associated with the procedure. The development of pleurisy four to six weeks after embolization has been reported, as has the onset of pulmonary hypertension or the worsening of prior pulmonary hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/13\">",
"     13",
"    </a>",
"    ]. The latter complication can be theoretically minimized in patients with large PAVM, multiple PAVM, or clinical evidence of either baseline pulmonary hypertension or an elevated cardiac output by estimating the post-treatment pulmonary hemodynamics prior to embolization. This estimation is made using two catheters; one catheter is used to occlude the pertinent vessel with a balloon (mimicking embolization) and a right heart catheter is used to measure the resulting pulmonary hemodynamics.",
"   </p>",
"   <p>",
"    Following embolization, patients should be monitored closely because of the propensity of some PAVM to enlarge and the risk of recanalization. One reasonable approach is to perform spiral chest computed tomography (CT) with thin slice formatting three to six months after embolization and then three years later. Failure to improve radiographically, worsening shunt, or new nodules warrant further evaluation for either continued perfusion of the PAVM or the development of new lesions. Contrast echocardiography is probably too sensitive for routine monitoring following embolotherapy, since it often remains positive despite successful occlusion of all angiographically visible vessels in 90 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576129\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is almost never the procedure of choice, but may rarely be the preferred option in patients with untreatable allergy to contrast material or PAVM that are not technically amenable to embolotherapy (very rare). Surgical techniques used to treat PAVM include vascular ligation, local excision, lobectomy, and pneumonectomy.",
"   </p>",
"   <p>",
"    Surgery to treat PAVM is associated with similar risks for morbidity and mortality as other types of thoracic surgery. Only one death out of 124 patients has been reported from complications of PAVM surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/3,21\">",
"     3,21",
"    </a>",
"    ]. Acute right heart failure has been rarely reported, likely due to removal of the low resistance PAVM with a subsequent acute increase in the pulmonary vascular resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical therapy is not always curative long-term. Recurrence or enlargement of PAVM has been reported in up to 12 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/4-6,29-31\">",
"     4-6,29-31",
"    </a>",
"    ]. In addition, enlargement of previously unrecognized PAVM and stroke have been reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576262\">",
"    <span class=\"h2\">",
"     Lung transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast majority of patients with PAVM respond to embolization",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    surgery. For the few patients that are refractory to such treatment, lung transplantation is an option, especially for those with diffuse bilateral disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. However, lung transplantation should be considered only for patients who are at considerable risk of dying from their underlying PAVM because severe postoperative hemorrhage and fatal multiorgan failure has occurred following transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26953?source=see_link\">",
"     \"Lung transplantation: General guidelines for recipient selection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576344\">",
"    <span class=\"h2\">",
"     Pharmacological therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of pharmacologic therapy in patients with PAVM is undefined. Pharmacological therapy for HHT is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=see_link&amp;anchor=H12129701#H12129701\">",
"     \"Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)\", section on 'Hormones and antifibrinolytic agents'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22767294\">",
"    <span class=\"h2\">",
"     Prevention of complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with PAVM are at risk for air embolism. Meticulous care should be taken to avoid the introduction of air bubbles when medications are given intravenously. This includes using in-line filters for all infused products, except radiographic contrast materials. Since the goal is to filter out macroscopic air bubbles, any type of blood (usually 170 to 260 microns) or in-line intravenous (0.22 to 0.45 micron) filter should be adequate. Patients with PAVM should also avoid SCUBA diving. Interestingly, despite the occurrence of hypoxemia in association with PAVM, in-flight complications are uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with PAVM are also at risk for cerebral abscess. Therefore, patients with discrete or diffuse PAVM should be given lifelong antibiotic prophylaxis prior to dental and other procedures to avoid bacteremia and the subsequent development of cerebral abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12358/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22767301\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary arteriovenous malformations (PAVM) are abnormal communications between pulmonary veins and arteries. PAVM are uncommon, but they are an important consideration in the differential diagnosis of common pulmonary problems, including hypoxemia, pulmonary nodules, and hemoptysis. (See",
"      <a class=\"local\" href=\"#H22766827\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most deaths attributable to PAVM are caused by stroke, cerebral abscess, hemoptysis, or hemothorax. However, the precise mortality rate is uncertain. Morbidity associated with PAVM is significant and includes stroke, transient ischemic attacks, and cerebral abscess. (See",
"      <a class=\"local\" href=\"#H22767252\">",
"       'Natural history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who have PAVM that are progressively enlarging, PAVM sacs greater than 2 cm in diameter, or have feeding vessels that are 2 to 3 mm or greater, as well as patients who have PAVM accompanied by symptomatic hypoxemia or a history of paradoxical embolism, we recommend treating the PAVM (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1575941\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatments available for PAVM include embolization, surgery, or lung transplantation. Embolization is preferred for almost all patients because it has a high success rate, is less invasive than the alternative procedures, and minimizes the loss of pulmonary parenchyma. Surgery may be preferable for patients with untreatable allergy to contrast material or PAVM that are not technically amenable to embolization. Lung transplantation is generally a therapy of last resort. (See",
"      <a class=\"local\" href=\"#H22767266\">",
"       'Embolization'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1576129\">",
"       'Surgery'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1576262\">",
"       'Lung transplantation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with PAVM are at increased risk for cerebral abscess and paradoxical air embolism. Therefore, patients should receive lifelong antibiotic prophylaxis prior to procedures and, when receiving intravenous fluids or medications, meticulous care (ie, use of filters) should be taken to avoid the introduction of air bubbles. (See",
"      <a class=\"local\" href=\"#H22767294\">",
"       'Prevention of complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/1\">",
"      Churton, T. Multiple aneurysms of the pulmonary artery. Br Med J 1897; 1:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/2\">",
"      SLOAN RD, COOLEY RN. Congenital pulmonary arteriovenous aneurysm. Am J Roentgenol Radium Ther Nucl Med 1953; 70:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/3\">",
"      Swanson KL, Prakash UB, Stanson AW. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. Mayo Clin Proc 1999; 74:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/4\">",
"      Dines DE, Arms RA, Bernatz PE, Gomes MR. Pulmonary arteriovenous fistulas. Mayo Clin Proc 1974; 49:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/5\">",
"      Sluiter-Eringa H, Orie NG, Sluiter HJ. Pulmonary arteriovenous fistula. Diagnosis and prognosis in noncomplainant patients. Am Rev Respir Dis 1969; 100:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/6\">",
"      Gomes MR, Bernatz PE, Dines DE. Pulmonary arteriovenous fistulas. Ann Thorac Surg 1969; 7:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/7\">",
"      Maher CO, Piepgras DG, Brown RD Jr, et al. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001; 32:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/8\">",
"      Moussouttas M, Fayad P, Rosenblatt M, et al. Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 2000; 55:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/9\">",
"      Vase P, Holm M, Arendrup H. Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia. Acta Med Scand 1985; 218:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/10\">",
"      Dines DE, Seward JB, Bernatz PE. Pulmonary arteriovenous fistulas. Mayo Clin Proc 1983; 58:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/11\">",
"      Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011; 48:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/12\">",
"      White RI Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996; 7:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/13\">",
"      Lee DW, White RI Jr, Egglin TK, et al. Embolotherapy of large pulmonary arteriovenous malformations: long-term results. Ann Thorac Surg 1997; 64:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/14\">",
"      Watanabe N, Munakata Y, Ogiwara M, et al. A case of pulmonary arteriovenous malformation in a patient with brain abscess successfully treated with video-assisted thoracoscopic resection. Chest 1995; 108:1724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/15\">",
"      Dutton JA, Jackson JE, Hughes JM, et al. Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients. AJR Am J Roentgenol 1995; 165:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/16\">",
"      Faughnan ME, Lui YW, Wirth JA, et al. Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. Chest 2000; 117:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/17\">",
"      Pierucci P, Murphy J, Henderson KJ, et al. New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: twenty-seven-year experience. Chest 2008; 133:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/18\">",
"      Pugash RA. Pulmonary arteriovenous malformations: overview and transcatheter embolotherapy. Can Assoc Radiol J 2001; 52:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/19\">",
"      Hart JL, Aldin Z, Braude P, et al. Embolization of pulmonary arteriovenous malformations using the Amplatzer vascular plug: successful treatment of 69 consecutive patients. Eur Radiol 2010; 20:2663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/20\">",
"      Pollak JS, Saluja S, Thabet A, et al. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol 2006; 17:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/21\">",
"      Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 1998; 158:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/22\">",
"      Lacombe P, Lagrange C, Beauchet A, et al. Diffuse pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: long-term results of embolization according to the extent of lung involvement. Chest 2009; 135:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/23\">",
"      Terry PB, White RI Jr, Barth KH, et al. Pulmonary arteriovenous malformations. Physiologic observations and results of therapeutic balloon embolization. N Engl J Med 1983; 308:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/24\">",
"      Chilvers ER, Whyte MK, Jackson JE, et al. Effect of percutaneous transcatheter embolization on pulmonary function, right-to-left shunt, and arterial oxygenation in patients with pulmonary arteriovenous malformations. Am Rev Respir Dis 1990; 142:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/25\">",
"      Pennington DW, Gold WM, Gordon RL, et al. Treatment of pulmonary arteriovenous malformations by therapeutic embolization. Rest and exercise physiology in eight patients. Am Rev Respir Dis 1992; 145:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/26\">",
"      Barzilai B, Waggoner AD, Spessert C, et al. Two-dimensional contrast echocardiography in the detection and follow-up of congenital pulmonary arteriovenous malformations. Am J Cardiol 1991; 68:1507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/27\">",
"      Lee WL, Graham AF, Pugash RA, et al. Contrast echocardiography remains positive after treatment of pulmonary arteriovenous malformations. Chest 2003; 123:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/28\">",
"      Sapru RP, Hutchison DC, Hall JI. Pulmonary hypertension in patients with pulmonary arteriovenous fistulae. Br Heart J 1969; 31:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/29\">",
"      Puskas JD, Allen MS, Moncure AC, et al. Pulmonary arteriovenous malformations: therapeutic options. Ann Thorac Surg 1993; 56:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/30\">",
"      BOSHER LH Jr, BLAKE DA, BYRD BR. An analysis of the pathologic anatomy of pulmonary arteriovenous aneurysms with particular reference to the applicability of local excision. Surgery 1959; 45:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/31\">",
"      Rodan BA, Goodwin JD, Chen JT, Ravin CE. Worsening pulmonary hypertension after resection of arteriovenous fistula. AJR Am J Roentgenol 1981; 137:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/32\">",
"      Reynaud-Gaubert M, Thomas P, Gaubert JY, et al. Pulmonary arteriovenous malformations: lung transplantation as a therapeutic option. Eur Respir J 1999; 14:1425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/33\">",
"      Svetliza G, De la Canal A, Beveraggi E, et al. Lung transplantation in a patient with arteriovenous malformations. J Heart Lung Transplant 2002; 21:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12358/abstract/34\">",
"      Mason CG, Shovlin CL. Flight-related complications are infrequent in patients with hereditary haemorrhagic telangiectasia/pulmonary arteriovenous malformations, despite low oxygen saturations and anaemia. Thorax 2012; 67:80.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16891 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-42B5A9483A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12358=[""].join("\n");
var outline_f12_4_12358=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22767301\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22766827\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22767252\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1575941\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1576056\">",
"      THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22767266\">",
"      Embolization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1576129\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1576262\">",
"      Lung transplantation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1576344\">",
"      Pharmacological therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22767294\">",
"      Prevention of complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22767301\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=related_link\">",
"      Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26953?source=related_link\">",
"      Lung transplantation: General guidelines for recipient selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32263?source=related_link\">",
"      Pulmonary arteriovenous malformations: Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27656?source=related_link\">",
"      Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_4_12359="ECG Ebstein anomaly";
var content_f12_4_12359=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 542px\">",
"   <div class=\"ttl\">",
"    Electrocardiogram Ebstein anomaly",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 522px; height: 311px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The electrocardigram of an infant with Ebstein anomaly shows tall, peaked P waves in leads II and V1 (arrows), compatible with right atrial hypertrophy, a right axis deviation (rS in leads I and aVL), and right bundle branch block pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12359=[""].join("\n");
var outline_f12_4_12359=null;
var title_f12_4_12360="Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity";
var content_f12_4_12360=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12360/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12360/contributors\">",
"     Richard Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12360/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12360/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12360/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12360/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12360/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/4/12360/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Apnea of prematurity is a developmental disorder in premature infants that is a consequence of immature respiratory control. Apnea of prematurity is most widely defined as cessation of breathing for more than 20 seconds, or a shorter respiratory pause that is accompanied by decreases in oxyhemoglobin desaturation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bradycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/1\">",
"     1",
"    </a>",
"    ]. The frequency of symptoms is inversely proportional to gestational age, and almost all infants with a gestational age less than 28 weeks are affected.",
"   </p>",
"   <p>",
"    The pathogenesis, diagnosis, and clinical presentation of apnea of prematurity are reviewed here. The management of apnea of prematurity is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/13/43223?source=see_link\">",
"     \"Management of apnea of prematurity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H372637432\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H372637715\">",
"    <span class=\"h2\">",
"     Apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Apnea is defined as the cessation of respiratory airflow. Short breathing pauses (5 to 10 seconds) occur frequently in premature infants and are normal.",
"   </p>",
"   <p>",
"    Apnea of prematurity is most widely defined as cessation of breathing for more than 20 seconds or a shorter respiratory pause associated with oxygen desaturation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bradycardia in infants who are younger than 37 weeks gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/1\">",
"     1",
"    </a>",
"    ]. Apnea of infancy refers to infants with a gestational age of 37 weeks or greater at the onset of apnea.",
"   </p>",
"   <p>",
"    Apnea is classified as central, obstructive, or mixed depending on the presence of continued inspiratory efforts and upper airway obstruction.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Central apnea &ndash; Inspiratory efforts are absent",
"     </li>",
"     <li>",
"      Obstructive apnea &ndash; Inspiratory efforts persist, but are ineffective in the presence of upper airway obstruction",
"     </li>",
"     <li>",
"      Mixed apnea &ndash; Upper airway obstruction with inspiratory efforts that precedes or follows central apnea",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most apnea spells in premature infants are central or mixed. This was illustrated in a study of physiologic recordings of 2082 apneic episodes in 47 infants: 40 percent of episodes were central, 50 percent were mixed, and 11 percent were obstructive [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/2\">",
"     2",
"    </a>",
"    ]. Of note, longer episodes are most likely to be mixed apnea as opposed to short respiratory pauses, which are primarily classified as central apnea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H372637696\">",
"    <span class=\"h2\">",
"     Periodic breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Periodic breathing episodes are characterized by a pattern of alternating breaths and brief respiratory pauses. Although descriptions vary, periodic breathing is usually defined as repetitive cycles of breathing and respiratory pauses that are about 5 to 10 seconds in duration. These pauses may be accompanied by modest oxygen desaturation and bradycardia that do not require clinical intervention. Periodic breathing is common in premature infants. It needs to be differentiated from apnea of prematurity as it typically does not require intervention. In some infants, episodes of severe decreases in SpO",
"    <sub>",
"     2",
"    </sub>",
"    need to be addressed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303561983\">",
"    <span class=\"h2\">",
"     Irregular breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Irregular breathing is commonly associated with rapid eye movement (REM) sleep but is not directly associated with either periodic breathing or apnea of prematurity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H372637470\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of apnea increases with decreasing gestational age.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Term infants &ndash; The incidence of apnea in term infants is quite low [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/3\">",
"       3",
"      </a>",
"      ]. As a result, the cause of apnea in term infants should be assumed to be pathologic and can include infection, severe birth asphyxia, intracranial hemorrhage or stroke, drug depression, and micrognathia with obstruction of the airway. (See",
"      <a class=\"local\" href=\"#H723201127\">",
"       'Differential diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Moderately preterm infants &ndash; In a multicenter study, apnea was diagnosed in 50 percent of infants born between 33 and 34",
"      <span class=\"nowrap\">",
"       6/7",
"      </span>",
"      weeks gestation based on documentation in the medical record [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/4\">",
"       4",
"      </a>",
"      ]. Persistent apnea was associated with longer hospitalization. However, there was a wide range in the rate of apnea among the neonatal intensive care units (NICUs) as the criteria for diagnosing apnea varied. The authors speculated that the true incidence of apnea was underestimated because of underreporting of events.",
"     </li>",
"     <li>",
"      Very preterm infants &ndash; Apnea occurs in virtually all infants born at less than 28 weeks&rsquo; gestation based on review of cardiorespiratory recordings from pneumography and cardiac and pulse oximetry monitoring [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. Infants born at 24 to 28 weeks&rsquo; gestation may continue to exhibit apnea beyond 38 weeks postconception, which prolongs their hospitalization [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/5\">",
"       5",
"      </a>",
"      ], although resolution of apnea is typically complete by around 43 to 44 weeks postmenstrual age (PMA) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Apnea of prematurity is a developmental disorder that reflects physiologic immaturity rather than a pathologic process. In fetal life, gas exchange occurs via the placenta, and respiratory muscle activity is intermittent. At delivery, the change to postnatal life requires continuous respiratory muscle activity to sustain gas exchange. However, the mechanisms underlying the transition from intermittent to continuous breathing are not fully understood. It is thought that apnea of prematurity is due to disruption of these developmental ventilation control processes due to immaturity resulting in impaired respiratory drive",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    failure to maintain airway patency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40008?source=see_link\">",
"     \"Control of ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H366813926\">",
"    <span class=\"h2\">",
"     Respiratory drive",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central respiratory drive initiates inspiratory effort in response to changes in arterial pCO",
"    <sub>",
"     2",
"    </sub>",
"    , pO",
"    <sub>",
"     2",
"    </sub>",
"    , and pH via input from neural and chemical receptors. The respiratory center in the brain integrates receptor input and transmits neuronal signals via efferent pathways to the respiratory muscles.",
"   </p>",
"   <p>",
"    In preterm infants, the immaturity of breathing responses affects all levels of respiratory control, including central and peripheral chemosensitivity and inhibitory pulmonary neuronal signal [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/8\">",
"     8",
"    </a>",
"    ]. Based on limited data from physiologic studies in preterm infants and animal studies, the following observations have been made regarding the pathogenesis of central respiratory drive impairment in preterm infants with apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the fetus, descending inhibition from central nervous structures above the brainstem and respiratory depression from the normally low fetal PaO",
"      <sub>",
"       2",
"      </sub>",
"      (~25 mmHg) contribute to decrease fetal respiratory activity. After premature delivery, these mechanisms appear to persist until the infant is able to developmentally adapt to the extrauterine environment.",
"     </li>",
"     <li>",
"      Histologic analysis demonstrates a decreased number of synaptic connections, dendritic arborizations, impaired astrocyte development, and poor myelination. These findings suggest immaturity of the brain contributes to poor ventilatory control.",
"     </li>",
"     <li>",
"      Upregulation of inhibitory neurotransmitters regulates respiratory control such as adenosine, gamma aminobutyric acid (GABA), and endorphins.",
"     </li>",
"     <li>",
"      A (yet to be determined) genetic component appears to be associated with apnea of prematurity as illustrated by the higher concordance rate of apnea among monozygotic preterm twin pairs compared with same gender dizygotic twins (87 versus 62 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In preterm infants with apnea, these and other yet to be identified factors appear to disrupt central respiratory drive as manifested by the impaired ventilatory response to hypercapnia and hypoxia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypercapnia &ndash; The major chemical driver of central respiratory output is elevated carbon dioxide (CO",
"      <sub>",
"       2",
"      </sub>",
"      ), which is sensed primarily through brainstem receptors with a smaller contribution from peripheral chemoreceptors in the carotid and aortic bodies. Preterm infants have a blunted ventilatory response to inhaled CO",
"      <sub>",
"       2",
"      </sub>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. The response to CO",
"      <sub>",
"       2",
"      </sub>",
"      is even lower in preterm infants with apnea compared with preterm controls matched by gestational age, birth weight, and postnatal age [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/12\">",
"       12",
"      </a>",
"      ]. This decreased ventilatory response at a given CO",
"      <sub>",
"       2",
"      </sub>",
"      level is primarily due to changes in central respiratory drive rather than pulmonary mechanics.",
"     </li>",
"     <li>",
"      Hypoxia &ndash; Increase in ventilation in response to hypoxia is almost exclusively dependent on feedback from carotid body peripheral chemoreceptors situated in the thorax. Premature infants have a biphasic response to hypoxia with an initial increase (hyperventilation) and subsequent decrease in inspiratory efforts (hypoventilation and sometimes apnea) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/13\">",
"       13",
"      </a>",
"      ]. This biphasic response to hypoxia can persist for several weeks postmenstrual age (PMA) and may contribute to the persistence of apnea in some infants [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/14\">",
"       14",
"      </a>",
"      ]. Although adults may also exhibit a biphasic ventilatory response to hypoxia, the degree of respiratory depression (following the initial increase in ventilation) is not as severe.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Decreased peripheral chemosensitivity in response to hypoxia may delay recovery from apnea. As noted above, the normally low fetal PaO",
"      <sub>",
"       2",
"      </sub>",
"      results in decreased fetal respiratory activity. With the fourfold increase in oxygen levels at birth, the peripheral chemoreceptors, which have adapted to the low fetal oxygen levels, are initially unresponsive until a subsequent increase in their sensitivity to extrauterine oxygen levels. However, the underlying mechanisms leading to this maturation remain unclear.",
"     </li>",
"     <li>",
"      Increased peripheral chemoreceptor responses to hypoxia have also been shown to destabilize breathing in preterm infants and contribute to periodic breathing [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/15\">",
"       15",
"      </a>",
"      ]. This has been attributed to the fact that the eupneic and apneic pCO",
"      <sub>",
"       2",
"      </sub>",
"      thresholds are very close in preterm infants, and frequent oscillations in breathing elicited by increased peripheral chemosensitivity may drive the eupneic pCO",
"      <sub>",
"       2",
"      </sub>",
"      below the pCO",
"      <sub>",
"       2",
"      </sub>",
"      threshold and induce apnea [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89276269\">",
"    <span class=\"h2\">",
"     Upper airway patency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patency of the upper airway is essential to the flow of respiratory gases between the environment and the alveolar-capillary interface.",
"   </p>",
"   <p>",
"    Factors associated with upper airway obstruction in preterm infants include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Collapse of the airway due to poor hypopharyngeal muscle tone",
"     </li>",
"     <li>",
"      Inhibitory upper airway reflexes",
"     </li>",
"     <li>",
"      Nasal obstruction",
"     </li>",
"     <li>",
"      Laryngeal edema and tracheal stenosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H709775314\">",
"    <span class=\"h3\">",
"     Hypopharynx",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maintenance of upper airway patency is dependent on the resting tone and active contraction of the hypopharyngeal muscles (",
"    <a class=\"graphic graphic_figure graphicRef71155 \" href=\"UTD.htm?21/50/22304\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/16\">",
"     16",
"    </a>",
"    ]. The hypopharynx is a frequent site of upper airway obstruction in premature infants because pharyngeal muscle tone is poor, resulting in airway collapse, especially during rapid eye movement (REM) sleep. The infant&rsquo;s airway is especially susceptible to collapse when the neck is flexed [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H747140\">",
"    <span class=\"h3\">",
"     Upper airway reflexes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Activation or stimulation of inhibitory upper airway reflexes (also referred to as the laryngeal chemoreflex) may contribute to the pathogenesis of apnea, although the mechanism is poorly understood. This reflex appears to be mediated through irritant receptors in the larynx. The reflex response evolves from apnea and bradycardia in early postnatal life to protective coughing and swallowing with advancing maturation. In newborn animal models, for example, milk from a different species or water instilled in the airway resulted in decreased ventilation or apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/18\">",
"     18",
"    </a>",
"    ]. In human infants, prolonged hypopharyngeal suctioning or aspiration of small volumes of milk also may induce this apneic response [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/19\">",
"     19",
"    </a>",
"    ]. However, no temporal relationship has been demonstrated between apnea of prematurity and gastroesophageal reflux. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23657?source=see_link&amp;anchor=H12#H12\">",
"     \"Gastroesophageal reflux in premature infants\", section on 'Relationship to apnea'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Viral infections with respiratory syncytial virus (RSV) may also enhance this apneic response, which is a common manifestation of RSV infection. In addition, upper respiratory infection may cause edema and obstruction of the airway. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H16#H16\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Apnea'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H747224\">",
"    <span class=\"h3\">",
"     Nasal obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Newborn infants depend upon a patent nasal airway for adequate ventilation because neonates are obligate or preferential nose breathers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/20\">",
"     20",
"    </a>",
"    ]. Therefore, apnea may be precipitated by intermittent nasal obstruction from swelling that may occur in association with excessive suctioning during prolonged nasal continuous positive airway pressure (CPAP), or with prolonged use of nasogastric tubes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H709775321\">",
"    <span class=\"h3\">",
"     Larynx and trachea",
"    </span>",
"    &nbsp;&mdash;&nbsp;The larynx and trachea are less common sites of mechanical airway obstruction because these rigid structures are less likely to collapse than the hypopharynx. Nevertheless, mild obstruction caused by laryngeal edema, vocal cord dysfunction, tracheal stenosis, or laryngeal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tracheal malacia can precipitate apnea in some cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89276472\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Apnea may become evident in the first two to three days after birth in premature infants who are breathing spontaneously without respiratory support or being treated with continuous positive airway pressure (CPAP). Breathing pauses usually are accompanied by bradycardia and hypoxemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In infants who are intubated and receiving mechanical ventilation, episodic desaturation and bradycardia are also quite common and are manifestations of ineffective ventilation and possibly cardiorespiratory reflex responses to airway stimulation by an endotracheal tube [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H747140\">",
"     'Upper airway reflexes'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Regardless of ventilatory mode, episodic desaturation in preterm infants typically increases in frequency after the second or third week of life [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/24\">",
"     24",
"    </a>",
"    ]. These episodes persist for several weeks, especially in infants who have a low baseline oxygen saturation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Apnea of prematurity typically resolves before 37 weeks postmenstrual age (PMA) in infants delivered after 28 weeks&rsquo; gestation. In contrast, in infants born before 28 weeks, apnea frequently persists till term PMA [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/5,6,26\">",
"     5,6,26",
"    </a>",
"    ]. However, significant apnea does not typically persist beyond 43 weeks PMA. This was best illustrated in a study that included 443 preterm infants (gestational age &le;34 weeks) that demonstrated significant cardiorespiratory events were rare beyond 43 weeks PMA and occurred no more frequently in the preterm group than in healthy term infants [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For infants without previous episodes of apnea after the first few weeks of life or who present with recurrent apnea after one to two weeks without apnea spells, the cause of apnea may be due to a serious underlying pathologic condition such as sepsis. These infants require a thorough evaluation to determine if there is a precipitating cause, which may be treatable. (See",
"    <a class=\"local\" href=\"#H723201127\">",
"     'Differential diagnosis'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H723201169\">",
"     'Evaluation to determine cause of apnea'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H731875161\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of apnea of prematurity is considered when either a respiratory pause greater than 20 seconds or a shorter respiratory pause accompanied by oxygen desaturation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bradycardia is detected in an infant with a gestational age less than 37 weeks. These events are typically identified by the routine use of cardiorespiratory monitors",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulse oximeters for preterm infants in the neonatal intensive care unit (NICU). Because apnea occurs in most infants born below 28 weeks&rsquo; gestation and in over half of more mature preterm infants, all preterm infants should be monitored for apnea. (See",
"    <a class=\"local\" href=\"#H372637470\">",
"     'Incidence'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    However, the diagnosis of apnea of prematurity is a diagnosis of exclusion. Other causes of apnea need to be considered and eliminated before the diagnosis of apnea of prematurity can be conclusively made. This is especially true for any preterm infant in whom there is a recent onset of apnea following a time period without apneic events. (See",
"    <a class=\"local\" href=\"#H723201127\">",
"     'Differential diagnosis'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H723201169\">",
"     'Evaluation to determine cause of apnea'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H731875168\">",
"    <span class=\"h2\">",
"     Respiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonatal cardiorespiratory monitors utilize impedance technology to measure respiration, which only measures chest wall motion. This technology is only effective to diagnose central apnea and the use of these apnea monitors will miss mixed apnea, which is frequently associated with upper airway closure and continued respiratory muscle activity and obstructive apnea. Monitoring heart rate and oxygen saturation with a pulse oximeter provides additional data to ensure that infants with both mixed and obstructive apnea that result in significant decreases in heart rate or SpO2 are also identified.",
"   </p>",
"   <p>",
"    Apnea monitor alarms are typically set to identify cessation of respirations of 15 to 20 seconds&rsquo; duration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H731875175\">",
"    <span class=\"h2\">",
"     Heart rate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart rate monitoring is important in the detection of apnea of prematurity, since bradycardia usually accompanies apnea of prematurity. The decreased heart rate is thought to be a reflex response to a fall in oxygenation. The most frequent reason for persistent cardiorespiratory alarms in preterm infants is short respiratory pauses (&lt;15 seconds) associated with bradycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/21\">",
"     21",
"    </a>",
"    ]. While many centers have traditionally set bradycardia alarms at &lt;80 beats per minute (bpm), we have lowered alarm settings to 70 bpm in convalescing preterm infants to decrease the frequency of alarms without apparent adverse affects. However, there are no data that determine the optimal threshold alarm setting for bradycardia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H731875182\">",
"    <span class=\"h2\">",
"     Pulse oximetry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulse oximeters are used as a frequent adjunct to cardiorespiratory monitors in the NICU. As with bradycardia alarms, they provide an additional safety measure for respiration monitors. Typically, the alarm settings are set to alarm at &lt;85 or &lt;80 oxygen saturation. The incidence and depth of oxygen desaturation episodes after apnea are dependent on pulmonary oxygen stores and baseline level oxygen saturations levels [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/25\">",
"     25",
"    </a>",
"    ]. As many preterm infants have low lung volumes associated with residual lung disease and a very compliant chest wall, they are vulnerable to frequent and deep falls in oxygen saturation with relatively short respiratory pauses. The time interval for the determination of the average oxygen saturation can be adjusted. A longer averaging time will smooth out the signal and decrease the numbers of alarms, but will not detect short oxygen desaturation periods [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H723201127\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although apnea of prematurity is the most common cause of apnea in preterm infants, it is a diagnosis of exclusion. The following etiologies that may present with apnea in preterm infants need to be considered and eliminated before the diagnosis of apnea of prematurity can be conclusively made.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hypoxemia",
"     </li>",
"     <li>",
"      Anemia",
"     </li>",
"     <li>",
"      Infection, including sepsis",
"     </li>",
"     <li>",
"      Metabolic disorders",
"     </li>",
"     <li>",
"      Unstable thermal environment (especially warming)",
"     </li>",
"     <li>",
"      Antepartum administration of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/29/34262?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      or opiates to the mother",
"     </li>",
"     <li>",
"      Administration of opiates or general anesthesia to the infant",
"     </li>",
"     <li>",
"      Neurologic disorders, including intracranial hemorrhage and neonatal encephalopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/26\">",
"       26",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Necrotizing enterocolitis (NEC)",
"     </li>",
"     <li>",
"      Congenital anomalies of the upper airway",
"     </li>",
"     <li>",
"      Seizures",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H723201169\">",
"    <span class=\"h1\">",
"     EVALUATION TO DETERMINE CAUSE OF APNEA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of the diagnostic evaluation is to differentiate apnea of prematurity from other causes of neonatal apnea. (See",
"    <a class=\"local\" href=\"#H723201127\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The diagnostic evaluation includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maternal and neonatal history",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Maternal administration of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/29/34262?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      or opioids",
"     </li>",
"     <li>",
"      Neonatal administration of opioid therapy",
"     </li>",
"     <li>",
"      Risk factors for neonatal sepsis",
"     </li>",
"     <li>",
"      Traumatic delivery",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      perinatal asphyxia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29623?source=see_link&amp;anchor=H3#H3\">",
"       \"Systemic effects of perinatal asphyxia\", section on 'Risk factors'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2442?source=see_link&amp;anchor=H8#H8\">",
"       \"Clinical features, diagnosis, and treatment of neonatal encephalopathy\", section on 'Diagnosis of neonatal asphyxia'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Infant of a diabetic mother (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=see_link\">",
"       \"Infant of a diabetic mother\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assessment of the infant for other signs of an underlying etiology",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Signs and symptoms of hypoglycemia (eg, jitteriness, hypotonia, and lethargy) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/16/17673?source=see_link&amp;anchor=H179706548#H179706548\">",
"       \"Neonatal hypoglycemia\", section on 'Who should be evaluated'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/16/17673?source=see_link&amp;anchor=H15#H15\">",
"       \"Neonatal hypoglycemia\", section on 'Clinical manifestations'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Signs and symptoms of sepsis (eg, temperature instability, lethargy, and poor feeding) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=see_link&amp;anchor=H8#H8\">",
"       \"Clinical features and diagnosis of sepsis in term and late preterm infants\", section on 'Clinical manifestations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=see_link&amp;anchor=H4#H4\">",
"       \"Clinical features and diagnosis of bacterial meningitis in the neonate\", section on 'Clinical features'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Signs and symptoms of neurologic impairment due to intraventricular hemorrhage, posthemorrhagic hydrocephalus, or neonatal encephalopathy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42697?source=see_link&amp;anchor=H18#H18\">",
"       \"Clinical manifestations and diagnosis of intraventricular hemorrhage in the newborn\", section on 'Clinical presentation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/46/31465?source=see_link&amp;anchor=H671769#H671769\">",
"       \"Management and complications of intraventricular hemorrhage in the newborn\", section on 'Posthemorrhagic hydrocephalus (PHH)'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29623?source=see_link&amp;anchor=H3#H3\">",
"       \"Systemic effects of perinatal asphyxia\", section on 'Risk factors'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2442?source=see_link&amp;anchor=H8#H8\">",
"       \"Clinical features, diagnosis, and treatment of neonatal encephalopathy\", section on 'Diagnosis of neonatal asphyxia'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Assessment of the airway to detect congenital anomalies of the upper airway (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/42/37543?source=see_link\">",
"       \"Congenital anomalies of the larynx\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35575?source=see_link\">",
"       \"Congenital anomalies of the nose\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link\">",
"       \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Signs and symptoms of necrotizing enterocolitis (NEC) (eg, abdominal distension, feeding intolerance, and bloody stools) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=see_link&amp;anchor=H4#H4\">",
"       \"Clinical features and diagnosis of necrotizing enterocolitis in newborns\", section on 'Clinical presentation'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oral feeds &ndash; Apnea of prematurity must be distinguished from the hypoxemia, cyanosis, and bradycardia sometimes associated with the introduction of oral feedings in premature infants. These changes in color and heart rate occur commonly before 34 to 36 weeks postmenstrual age (PMA) as a result of ineffective coordination of sucking, swallowing, and breathing, which may cause impaired ventilation. These events may persist in some neonates to 38 weeks PMA [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/27\">",
"       27",
"      </a>",
"      ]. High rates of milk flow may also contribute to reduced ventilation [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12360/abstract/28\">",
"       28",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/4/21576?source=see_link&amp;anchor=H10#H10\">",
"       \"Sucking and swallowing disorders in the newborn\", section on 'Feeding disorders'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Laboratory evaluation includes the following tests that may be helpful in identifying an underlying diagnosis:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Complete blood count: anemia and sepsis",
"     </li>",
"     <li>",
"      Blood culture: sepsis",
"     </li>",
"     <li>",
"      Measurements of blood glucose: hypoglycemia",
"     </li>",
"     <li>",
"      Blood gas: hypoxemia and acidosis, which may be present in patients with inborn errors of metabolism, sepsis, or NEC",
"     </li>",
"     <li>",
"      Other laboratory studies may be indicated if a metabolic disorder is suspected (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24489?source=see_link&amp;anchor=H4#H4\">",
"       \"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features\", section on 'Clinical manifestations'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cranial imaging should be obtained in cases in which intracranial hemorrhage, infarction, or neonatal encephalopathy is suspected. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42697?source=see_link&amp;anchor=H19#H19\">",
"       \"Clinical manifestations and diagnosis of intraventricular hemorrhage in the newborn\", section on 'Diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27690?source=see_link&amp;anchor=H10#H10\">",
"       \"Stroke in the newborn\", section on 'Imaging studies'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2442?source=see_link&amp;anchor=H3#H3\">",
"       \"Clinical features, diagnosis, and treatment of neonatal encephalopathy\", section on 'Neuroimaging'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72624116\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Apnea of prematurity is a developmental disorder in premature infants that occurs as a direct consequence of immature respiratory control.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Apnea of prematurity is most widely defined as cessation of breathing for more than 20 seconds or a shorter respiratory pause associated with oxygen desaturation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bradycardia in infants who are younger than 37 weeks&rsquo; gestation. Apnea is classified as central, obstructive, or mixed depending upon the presence of continued inspiratory effort and upper airway obstruction while respiratory airflow is absent. In premature infants, most apnea spells are classified as either being central or mixed. (See",
"      <a class=\"local\" href=\"#H372637715\">",
"       'Apnea'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The incidence of apnea is inversely proportional to gestational age, and almost all extremely low birth weight infants (gestational age &lt;28 weeks) are affected. (See",
"      <a class=\"local\" href=\"#H372637470\">",
"       'Incidence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although the exact mechanisms underlying apnea of prematurity are unknown, it is thought to be due to disruption of ventilation control processes due to immaturity that results in impaired central respiratory drive",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      inability to maintain upper airway patency. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Apnea of prematurity typically presents within the first few days of life in affected preterm infants who are not mechanically ventilated. It typically resolves before 37 postmenstrual weeks in infants delivered after 28 weeks&rsquo; gestation, but in infants born before 28 weeks, apnea frequently persists until 43 weeks postmenstrual age (PMA). (See",
"      <a class=\"local\" href=\"#H89276472\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of apnea of prematurity is considered when either cessation of breathing greater than 20 seconds or a shorter period of respiratory pause accompanied by oxygen desaturation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bradycardia is detected. These events are typically identified by the routine use of cardiorespiratory monitors",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pulse oximeters for preterm infants in the neonatal intensive care unit (NICU). Although apnea of prematurity is the most common cause of apnea in preterm infants, it is a diagnosis of exclusion. Other causes of apnea need to be considered and eliminated before the diagnosis of apnea of prematurity is made. (See",
"      <a class=\"local\" href=\"#H731875161\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H723201127\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The goal of the diagnostic evaluation is to identify any underlying cause (eg, sepsis). The evaluation is based on a comprehensive history and assessment of the infant and laboratory testing. (See",
"      <a class=\"local\" href=\"#H723201169\">",
"       'Evaluation to determine cause of apnea'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1972562\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. James M Adams, Jr, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/1\">",
"      Committee on Fetus and Newborn. American Academy of Pediatrics. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 2003; 111:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/2\">",
"      Finer NN, Barrington KJ, Hayes BJ, Hugh A. Obstructive, mixed, and central apnea in the neonate: physiologic correlates. J Pediatr 1992; 121:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/3\">",
"      Henderson-Smart DJ. The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies. Aust Paediatr J 1981; 17:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/4\">",
"      Eichenwald EC, Zupancic JA, Mao WY, et al. Variation in diagnosis of apnea in moderately preterm infants predicts length of stay. Pediatrics 2011; 127:e53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/5\">",
"      Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics 1997; 100:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/6\">",
"      Hofstetter AO, Legnevall L, Herlenius E, Katz-Salamon M. Cardiorespiratory development in extremely preterm infants: vulnerability to infection and persistence of events beyond term-equivalent age. Acta Paediatr 2008; 97:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/7\">",
"      Ramanathan R, Corwin MJ, Hunt CE, et al. Cardiorespiratory events recorded on home monitors: Comparison of healthy infants with those at increased risk for SIDS. JAMA 2001; 285:2199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/8\">",
"      Abu-Shaweesh JM, Martin RJ. Neonatal apnea: what's new? Pediatr Pulmonol 2008; 43:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/9\">",
"      Bloch-Salisbury E, Hall MH, Sharma P, et al. Heritability of apnea of prematurity: a retrospective twin study. Pediatrics 2010; 126:e779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/10\">",
"      Darnall RA. The role of CO(2) and central chemoreception in the control of breathing in the fetus and the neonate. Respir Physiol Neurobiol 2010; 173:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/11\">",
"      Rigatto H, Brady JP, de la Torre Verduzco R. Chemoreceptor reflexes in preterm infants: II. The effect of gestational and postnatal age on the ventilatory response to inhaled carbon dioxide. Pediatrics 1975; 55:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/12\">",
"      Gerhardt T, Bancalari E. Apnea of prematurity: I. Lung function and regulation of breathing. Pediatrics 1984; 74:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/13\">",
"      Rigatto H, Brady JP, de la Torre Verduzco R. Chemoreceptor reflexes in preterm infants: I. The effect of gestational and postnatal age on the ventilatory response to inhalation of 100% and 15% oxygen. Pediatrics 1975; 55:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/14\">",
"      Martin RJ, DiFiore JM, Jana L, et al. Persistence of the biphasic ventilatory response to hypoxia in preterm infants. J Pediatr 1998; 132:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/15\">",
"      Nock ML, Difiore JM, Arko MK, Martin RJ. Relationship of the ventilatory response to hypoxia with neonatal apnea in preterm infants. J Pediatr 2004; 144:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/16\">",
"      Reed WR, Roberts JL, Thach BT. Factors influencing regional patency and configuration of the human infant upper airway. J Appl Physiol 1985; 58:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/17\">",
"      Wilson SL, Thach BT, Brouillette RT, Abu-Osba YK. Upper airway patency in the human infant: influence of airway pressure and posture. J Appl Physiol 1980; 48:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/18\">",
"      Haddad GG, Mellins RB. The role of airway receptors in the control of respiration in infants: a review. J Pediatr 1977; 91:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/19\">",
"      Pickens DL, Schefft G, Thach BT. Prolonged apnea associated with upper airway protective reflexes in apnea of prematurity. Am Rev Respir Dis 1988; 137:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/20\">",
"      Miller MJ, Martin RJ, Carlo WA, et al. Oral breathing in newborn infants. J Pediatr 1985; 107:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/21\">",
"      Di Fiore JM, Arko MK, Miller MJ, et al. Cardiorespiratory events in preterm infants referred for apnea monitoring studies. Pediatrics 2001; 108:1304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/22\">",
"      Esquer C, Claure N, D'Ugard C, et al. Role of abdominal muscles activity on duration and severity of hypoxemia episodes in mechanically ventilated preterm infants. Neonatology 2007; 92:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/23\">",
"      Dimaguila MA, Di Fiore JM, Martin RJ, Miller MJ. Characteristics of hypoxemic episodes in very low birth weight infants on ventilatory support. J Pediatr 1997; 130:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/24\">",
"      Di Fiore JM, Bloom JN, Orge F, et al. A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J Pediatr 2010; 157:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/25\">",
"      Di Fiore JM, Walsh M, Wrage L, et al. Low oxygen saturation target range is associated with increased incidence of intermittent hypoxemia. J Pediatr 2012; 161:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/26\">",
"      Darnall RA, Kattwinkel J, Nattie C, Robinson M. Margin of safety for discharge after apnea in preterm infants. Pediatrics 1997; 100:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/27\">",
"      Shivpuri CR, Martin RJ, Carlo WA, Fanaroff AA. Decreased ventilation in preterm infants during oral feeding. J Pediatr 1983; 103:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12360/abstract/28\">",
"      Mathew OP. Breathing patterns of preterm infants during bottle feeding: role of milk flow. J Pediatr 1991; 119:960.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5052 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-08BE826B45-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12360=[""].join("\n");
var outline_f12_4_12360=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H72624116\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H372637432\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H372637715\">",
"      Apnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H372637696\">",
"      Periodic breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303561983\">",
"      Irregular breathing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H372637470\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H366813926\">",
"      Respiratory drive",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H89276269\">",
"      Upper airway patency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H709775314\">",
"      - Hypopharynx",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H747140\">",
"      - Upper airway reflexes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H747224\">",
"      - Nasal obstruction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H709775321\">",
"      - Larynx and trachea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89276472\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H731875161\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H731875168\">",
"      Respiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H731875175\">",
"      Heart rate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H731875182\">",
"      Pulse oximetry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H723201127\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H723201169\">",
"      EVALUATION TO DETERMINE CAUSE OF APNEA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H72624116\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1972562\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5052\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5052|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/50/22304\" title=\"figure 1\">",
"      Breathing forces on pharynx",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=related_link\">",
"      Clinical features and diagnosis of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=related_link\">",
"      Clinical features and diagnosis of necrotizing enterocolitis in newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=related_link\">",
"      Clinical features and diagnosis of sepsis in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2442?source=related_link\">",
"      Clinical features, diagnosis, and treatment of neonatal encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42697?source=related_link\">",
"      Clinical manifestations and diagnosis of intraventricular hemorrhage in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=related_link\">",
"      Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/42/37543?source=related_link\">",
"      Congenital anomalies of the larynx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35575?source=related_link\">",
"      Congenital anomalies of the nose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40008?source=related_link\">",
"      Control of ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23657?source=related_link\">",
"      Gastroesophageal reflux in premature infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24489?source=related_link\">",
"      Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=related_link\">",
"      Infant of a diabetic mother",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/46/31465?source=related_link\">",
"      Management and complications of intraventricular hemorrhage in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/13/43223?source=related_link\">",
"      Management of apnea of prematurity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/16/17673?source=related_link\">",
"      Neonatal hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=related_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27690?source=related_link\">",
"      Stroke in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/4/21576?source=related_link\">",
"      Sucking and swallowing disorders in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29623?source=related_link\">",
"      Systemic effects of perinatal asphyxia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_4_12361="Echocardiography in detection of intracardiac sources of embolism";
var content_f12_4_12361=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Echocardiography in detection of intracardiac sources of embolism",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12361/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12361/contributors\">",
"     Warren J Manning, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12361/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12361/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12361/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12361/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/4/12361/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 10, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracardiac sources of cerebrovascular ischemic events are increasingly being recognized and may account for 15 to 20 percent of the 500,000 strokes which occur annually in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/1\">",
"     1",
"    </a>",
"    ]. Although transthoracic echocardiography (TTE) remains the cornerstone of noninvasive cardiac imaging, transesophageal echocardiography (TEE) has been shown to be a superior method for the identification of most cardiac sources of emboli [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/2,3\">",
"     2,3",
"    </a>",
"    ], and more cost effective [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    TEE is a moderately invasive procedure during which a modified gastroscope (containing an ultrasound crystal at its tip) is blindly introduced into the esophagus. Imaging is performed within the esophagus and the gastric fundus. The close proximity of the esophagus to the posterior heart, the lack of intervening lung and bone, and the use of higher-frequency imaging transducers results in enhanced spatial resolution and improved detection of intracardiac thrombi and tumors, patent foramen ovale, valvular vegetations, atheromatous thoracic aortic plaques, and spontaneous left atrial echo contrast, a marker of blood stasis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/2,3,5\">",
"     2,3,5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38280?source=see_link\">",
"     \"Transesophageal echocardiography: Indications, complications, and normal views\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The enhanced value of TEE can be illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report of 79 patients with cryptogenic stroke, TEE identified a potential cardiac source of embolism in 57 percent compared with only 15 percent by transthoracic echocardiography [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/2\">",
"       2",
"      </a>",
"      ]. A patent foramen ovale, which is an important cause of cryptogenic stroke, is not considered to represent a cardiac cause since the embolus derives from the venous circulation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/32/3593?source=see_link\">",
"       \"Patent foramen ovale\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39689?source=see_link\">",
"       \"Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Another study evaluated 30 patients with a stroke who were in sinus rhythm, had no cardiac disease related to embolism, and had minimal carotid artery stenosis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/5\">",
"       5",
"      </a>",
"      ]. In these patients deemed to be at low risk for embolism, TTE found no embolic sources; in contrast, TEE showed thrombus in the left atrial appendage in three, atrial septal aneurysm in two, a patent foramen ovale in seven, and aortic plaques in nineteen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Evaluation for a possible cardiac source of embolism is currently the leading clinical indication for TEE [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. One limitation of TEE is difficulty in imaging the left ventricular apex. As a result, assessment of left ventricular systolic function and identification of left ventricular apical thrombi are best appreciated by TTE.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MAJOR SOURCES OF EMBOLI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potential cardiac sources of emboli can be categorized into masses (including thrombi, atherosclerotic plaques, vegetations, and tumors), passageways for paradoxical embolism (patent foramen ovale, atrial septal defects), and a propensity for thrombus formation (left atrial spontaneous echo contrast, mitral annular calcification). The most common are left atrial and left ventricular thrombi, left atrial spontaneous echo contrast, and aortic atherosclerosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Left atrial thrombi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Left atrial thrombi, most often associated with atrial fibrillation (AF)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    rheumatic mitral stenosis, account for over 45 percent of cardiogenic thromboemboli. One study of 2894 consecutive patients who underwent TEE for various indications, found a left atrial thrombus in 94 (3 percent); 83 of these patients were in AF [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/8\">",
"     8",
"    </a>",
"    ]. Another study of 869 patients presenting with an embolic stroke or a transient ischemic episode found that a left atrial thrombus was seen in only 1 percent of those with sinus rhythm and no mitral valve disease or left atrial dysfunction; routine TEE in such patients is not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TEE studies show evidence of left atrial thrombi in 14 percent of patients with acute AF, 27 percent of those with chronic AF [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/10\">",
"     10",
"    </a>",
"    ], and 43 percent in those presenting with AF and clinical thromboembolism (",
"    <a class=\"graphic graphic_figure graphicRef81863 \" href=\"UTD.htm?14/45/15071\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef73470 \" href=\"UTD.htm?25/10/25775\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef51472 \" href=\"UTD.htm?10/61/11231\">",
"     movie 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/11\">",
"     11",
"    </a>",
"    ]. Recurrent embolization in the last setting may be due to migration of the residual thrombus. On the other hand, the apparent lack of thrombi in 57 percent of these patients probably reflects migration of the entire thrombus during the embolic event or another source for the embolus [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    TEE offers detailed visualization of the left atrium, including the atrial appendage, which is the main site of thrombus formation (",
"    <a class=\"graphic graphic_movie graphicRef56080 \" href=\"UTD.htm?23/51/24383\">",
"     movie 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef66795 \" href=\"UTD.htm?4/61/5072\">",
"     movie 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef75036 \" href=\"UTD.htm?4/11/4287\">",
"     movie 5",
"    </a>",
"    ). In one intraoperative study, for example, TEE was compared with direct visualization of left atrial contents at surgery: the sensitivity and specificity of TEE for thrombi were 100 and 99 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/12\">",
"     12",
"    </a>",
"    ]. In comparison, conventional two-dimensional TTE has a sensitivity of only 39 to 65 percent for left atrial thrombi due to poor visualization of the left atrial appendage [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/12\">",
"     12",
"    </a>",
"    ]. Multiplane is the standard for the assessment of possible left atrial thrombi. Anecdotal reports suggest that three-dimensional (3D) TEE is also excellent, but no large comparative studies have been reported.",
"   </p>",
"   <p>",
"    Systemic emboli occur in patients with dilated cardiomyopathy at the rate of 4 percent per year. Historically, left ventricular thrombi had been presumed to be the source of emboli in these patients and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    has been recommended for the prevention of thromboembolism in this group [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/13\">",
"     13",
"    </a>",
"    ]. However, TEE studies have shown that left atrial thrombi are the more likely culprit, being four times as frequent in patients with dilated cardiomyopathy and thromboembolism [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7048?source=see_link\">",
"     \"Indications for antithrombotic therapy in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Left atrial spontaneous echo contrast",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous echo contrast or \"smoke-like\" echoes seen within the left atrium during high frequency imaging of TEE is the most common TEE finding among patients referred for evaluation of a possible cardiac source of embolism, especially in those with AF or left atrial enlargement (",
"    <a class=\"graphic graphic_movie graphicRef73470 \" href=\"UTD.htm?25/10/25775\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef51472 \" href=\"UTD.htm?10/61/11231\">",
"     movie 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef56080 \" href=\"UTD.htm?23/51/24383\">",
"     movie 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef66795 \" href=\"UTD.htm?4/61/5072\">",
"     movie 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66980 \" href=\"UTD.htm?17/50/18223\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spontaneous echo contrast may be seen in patients who are in sinus rhythm. This was illustrated in a review of 1288 TEE studies in which the incidence of spontaneous echo contrast was 2 percent; 13 percent of these patients had associated left atrial thrombus [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/17\">",
"     17",
"    </a>",
"    ]. All patients had an enlarged left atrium and reduced peak left atrial appendage emptying velocity.",
"   </p>",
"   <p>",
"    Spontaneous echo contrast may be present in patients with mitral stenosis who are in sinus rhythm, is associated with evidence of a hypercoagulable state, and may be stable over a prolonged period [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. In a review of 77 patients with nonrheumatic AF, the patients with left atrial spontaneous echo contrast on an initial echocardiogram continued to have this finding after a mean follow-up of 20 months [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/20\">",
"     20",
"    </a>",
"    ]. In addition, 44 percent of patients who did not initially have spontaneous echo contrast developed this finding during follow-up.",
"   </p>",
"   <p>",
"    Spontaneous echo contrast is believed to represent erythrocyte aggregation in low shear rate conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/21\">",
"     21",
"    </a>",
"    ]. Erythrocyte aggregation is mediated by plasma proteins, particularly fibrinogen, which promote red cell rouleaux formation by eliminating the normal electrostatic forces of red blood cells that result from their negative surface charge (and which keep them from aggregating) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spontaneous echo contrast has also been associated with elevated plasma fibrinogen concentration. In addition, over two-thirds of patients with mitral stenosis have TEE evidence of spontaneous echo contrast which is thought to indicate a relatively hypercoagulable state and atrial blood stasis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/15\">",
"     15",
"    </a>",
"    ]. The finding of elevated left atrial levels of prothrombin fragments 1 and 2 (markers of coagulation activity) among patients with spontaneous echo contrast and mitral stenosis also supports an association with a hypercoagulable state [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a very strong association between left atrial spontaneous echo contrast and left atrial thrombi. Among patients with AF and left atrial thrombi, for example, spontaneous echo contrast is seen in almost 80 percent of cases. This finding is an independent predictor of thromboembolic risk and, in patients with AF, is associated with an increase in embolic rate from three to 12 percent per year. Mitral regurgitation appears to lessen the frequency of spontaneous echo contrast. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Aortic atherosclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;TEE is a sensitive method for visualization of the aortic intima (",
"    <a class=\"graphic graphic_movie graphicRef76326 \" href=\"UTD.htm?18/15/18686\">",
"     movie 6",
"    </a>",
"    ). Aortic atherosclerotic plaques, which can be seen on TEE, are an important source of both thromboemboli and atheroemboli in patients with unexplained stroke, transient ischemic attack, and arterial embolization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10809?source=see_link\">",
"     \"Embolism from aortic plaque: Thromboembolism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/15/31994?source=see_link\">",
"     \"Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Left ventricular thrombi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Left ventricular thrombus is one of the most common complications of myocardial infarction. Such thrombi are important clinically because they can lead to embolic complications, including stroke. Echocardiography can document wall motion abnormalities that may underlie thrombus, the presence of thrombus and risk factors for embolization. The 2003",
"    <span class=\"nowrap\">",
"     ACC/AHA/ASE",
"    </span>",
"    task force gave a class I recommendation to the use of TTE for the assessment of mural thrombus after acute myocardial infarction (",
"    <a class=\"graphic graphic_movie graphicRef51575 \" href=\"UTD.htm?5/46/5871\">",
"     movie 7",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/24\">",
"     24",
"    </a>",
"    ]. Data suggest that for patients with ischemic heart disease, cardiac magnetic resonance is superior to both TEE and TTE for detection of intraventricular thrombi. Issues related to the diagnosis, prevention, and treatment of left ventricular thrombus are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5497?source=see_link\">",
"     \"Left ventricular thrombus after acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Prosthetic valve thrombi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thrombus formation and subsequent embolization are common in patients with mechanical valve prostheses, especially in those with a mitral or tricuspid prosthesis and suboptimal anticoagulation (",
"    <a class=\"graphic graphic_movie graphicRef64234 \" href=\"UTD.htm?30/38/31343\">",
"     movie 8",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/25\">",
"     25",
"    </a>",
"    ]. These patients require lifelong",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    anticoagulation with a recommended INR between 2.5 and 4.9 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25497?source=see_link\">",
"     \"Complications of prosthetic heart valves\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/11/18618?source=see_link\">",
"     \"Antithrombotic therapy in patients with prosthetic heart valves\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evaluation of prosthetic valves, especially mitral prostheses, is best performed by TEE. However, it is often assumed clinically that patients with mechanical prostheses who present with systemic embolization have prosthetic valve thrombi, especially if there is no other obvious cause",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the international normalized ratio (INR) is subtherapeutic. Thus, although TEE can confirm the diagnosis, it does not usually change therapy (except for patients with valvular dysfunction due to a massive thrombus).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Abnormalities of the interatrial septum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities of the interatrial septum are associated with thromboembolism via two pathophysiologic mechanisms: right-to-left shunting and interatrial septal aneurysm (",
"    <a class=\"graphic graphic_movie graphicRef50099 \" href=\"UTD.htm?24/40/25231\">",
"     movie 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef65962 \" href=\"UTD.htm?15/10/15524\">",
"     movie 10",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Interatrial shunt",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with an atrial septal defect or patent foramen ovale may have intermittent flow of blood from the right atrium to the left atrium (",
"    <a class=\"graphic graphic_movie graphicRef80448 \" href=\"UTD.htm?6/56/7040\">",
"     movie 11",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef79348 \" href=\"UTD.htm?22/39/23167\">",
"     movie 12",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef78654 \" href=\"UTD.htm?12/48/13057\">",
"     movie 13",
"    </a>",
"    ). This can be induced on a daily basis by coughing or Valsalva maneuvers (as with bowel movements). A thrombus in the venous system may therefore cross to the left side of the heart resulting in a systemic thromboembolism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/32/3593?source=see_link\">",
"     \"Patent foramen ovale\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39689?source=see_link\">",
"     \"Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TEE with contrast (intravenous injection of agitated saline), at rest, with cough, and following Valsalva release is the preferred diagnostic test in this setting (",
"    <a class=\"graphic graphic_movie graphicRef78654 \" href=\"UTD.htm?12/48/13057\">",
"     movie 13",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef56656 \" href=\"UTD.htm?32/20/33094\">",
"     movie 14",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/26\">",
"     26",
"    </a>",
"    ]. TTE with agitated saline is slightly less sensitive but may be adequate if the suspicion for a patent foramen ovale is low or the patient is not a candidate for TEE. In a retrospective review of 1162 consecutive patients who underwent TTE with agitated saline contrast injection, paradoxical right-to-left shunting was seen in 403 patients (35 percent), although 195 patients (48 percent of those with shunting) showed paradoxical shunting only following a provocative maneuver (ie, Valsalva maneuver) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/27\">",
"     27",
"    </a>",
"    ]. There was very good agreement between TTE and TEE, with 99 percent sensitivity and 85 percent specificity of TTE for making the diagnosis.",
"   </p>",
"   <p>",
"    Such a \"potential\" communication has been found in over 25 percent of normal hearts at autopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/28\">",
"     28",
"    </a>",
"    ]. The association between paradoxical emboli and cryptogenic stroke has been clearly established in patients less than 55 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]; a similar relationship is less certain in older patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. The finding of a potential communication has been considered presumptive evidence of a paradoxical embolus in patients with cryptogenic stroke. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/10/40105?source=see_link\">",
"     \"Cryptogenic stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical evidence for the thrombus source (such as deep venous thrombosis) is usually lacking. As an example, one study of 197 patients with an embolic stroke reported that 23 percent had a patent foramen ovale and 9.5 percent had deep vein thrombosis as documented with venography [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/32\">",
"     32",
"    </a>",
"    ]. In contrast, when peripheral venography was performed in 49 patients with systemic thromboembolism and patent foramen ovale by TEE, peripheral venous thrombosis was seen in 57 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/33\">",
"     33",
"    </a>",
"    ]. Almost two-thirds of the thrombi were limited to the calf or popliteal veins. The relative quantity of contrast (or severity of right-to-left shunting) appearing in the left atrium after venous injection also appears to be associated with increased risk [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Atrial septal aneurysm",
"    </span>",
"    &nbsp;&mdash;&nbsp;The second abnormality of the interatrial septum that is associated with thromboembolism is an atrial septal aneurysm (",
"    <a class=\"graphic graphic_movie graphicRef50099 \" href=\"UTD.htm?24/40/25231\">",
"     movie 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef65962 \" href=\"UTD.htm?15/10/15524\">",
"     movie 10",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef67067 \" href=\"UTD.htm?8/49/8983\">",
"     movie 15",
"    </a>",
"    ). This defect is a congenital malformation due to redundant atrial septal tissue, typically involving the region of the fossa ovalis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/35\">",
"     35",
"    </a>",
"    ]. Prevalence in the normal population is estimated to be 0.5 percent by TTE [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/36\">",
"     36",
"    </a>",
"    ] and up to 5 percent by TEE [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Embolic events can result from an associated patent foramen ovale (which may be present in over 75 percent of cases) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/39\">",
"     39",
"    </a>",
"    ], or from direct thrombus formation in the neck of the aneurysm [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Retrospective studies of patients with a stroke have found that approximately 10 percent have an interatrial septal aneurysm [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/32\">",
"     32",
"    </a>",
"    ], but one prospective trial found that the incidence of embolic strokes associated with an atrial septal defect is low [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/38\">",
"     38",
"    </a>",
"    ]. Among 846 patients undergoing TEE during cardiac surgery, 4.9 percent had an atrial septal aneurysm as an incidental finding; 56 percent of these patients had a patent aneurysm and 67 percent were treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    . There were no cerebrovascular events or systemic embolization during a 70 month follow-up. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39689?source=see_link\">",
"     \"Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LESS COMMON CARDIAC SOURCES OF EMBOLI",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of other causes of cardiac embolization that are less common than those described above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Infective endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Embolization of valvular vegetations can result in cerebral ischemia. We begin with transthoracic echocardiography in patients with suspected endocarditis and native heart valves, because it is easier to perform than TEE. Detection of a vegetation is a positive test. However, TTE has relatively low sensitivity in infective endocarditis. Thus, a negative study does not preclude the diagnosis and should be followed by TEE which has higher spatial resolution and improved image quality (",
"    <a class=\"graphic graphic_movie graphicRef73652 \" href=\"UTD.htm?22/46/23279\">",
"     movie 16",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef52651 \" href=\"UTD.htm?30/9/30867\">",
"     movie 17",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef65848 \" href=\"UTD.htm?29/38/30306\">",
"     movie 18",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A prospective study of 96 patients with suspected endocarditis, for example, revealed a sensitivity for the detection of vegetations of 100 percent with TEE compared to 63 percent with TTE [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/41\">",
"     41",
"    </a>",
"    ]. In a second report, TTE and TEE were compared in 66 episodes of suspected endocarditis: TEE had a sensitivity of 94 percent versus 44 percent with TTE. Both methods had specificity (the likelihood of a negative result in a patient without the disease) approaching 100 percent, indicating very few false positives [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/42\">",
"     42",
"    </a>",
"    ]. Thus, a negative study indicates a low probability of disease. Thromboembolism is related both to vegetation size and mobility [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/23/31094?source=see_link\">",
"     \"Infective endocarditis: Historical and Duke criteria\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The likelihood that TEE will demonstrate vegetations is quite low in the absence of a clinical history suggestive of endocarditis. As a result, screening all patients with possible cardiac source of emboli with TEE is not likely to be beneficial or cost effective.",
"   </p>",
"   <p>",
"    Mobile, filamentous echo densities have been described on aortic and mitral leaflets of native valves and on prosthetic valves among patients (especially elderly adults) who undergo TEE for indications other than \"source of embolism\" or \"endocarditis\" [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. These echo densities are felt to represent fibrin strands. An increased prevalence of these thread-like echo densities has been described in patients with a recent cerebral ischemic event [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. Similar TEE findings have been described on apparently normal functioning prosthetic valves in the absence of an embolic history.",
"   </p>",
"   <p>",
"    Thus, while echocardiography can document the presence of vegetations, it is not helpful for predicting embolization. One study of 57 patients with infective endocarditis who had a TTE and TEE reported that no echocardiographic characteristics of the vegetations were predictive of an embolic event, which subsequently occurred in 44 percent of the patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Nonbacterial thrombotic endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term nonbacterial thrombotic endocarditis (NBTE), or marantic endocarditis, refers to a spectrum of lesions ranging from microscopic aggregates of platelets to large vegetations on the heart valves (most often aortic and mitral), usually in patients with advanced malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=see_link&amp;anchor=H20#H20\">",
"     \"Hypercoagulable disorders associated with malignancy\", section on 'Nonbacterial thrombotic endocarditis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The potential value of TEE in this setting was illustrated in a series of 51 consecutive cancer patients with cerebrovascular events who were referred for TEE [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/48\">",
"     48",
"    </a>",
"    ]. Almost one-half of patients had a definite cardiac source of embolism. Nonbacterial vegetations were detected in nine (18 percent); TTE was performed in seven of these patients and was negative in four. Other sources of embolism included left atrial thrombus, complex aortic atheroma, and a patent foramen ovale or atrial septal defect in the presence of venous thromboembolism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Intracardiac tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary cardiac tumors are found in only 0.002 to 0.03 percent of autopsy studies, with myxomas constituting more than 50 percent of these lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/32/17930?source=see_link\">",
"     \"Cardiac tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Myxomas are histologically benign tumors that typically form within the left atrium; they are attached to the interatrial septum in the area of the foramen, and are frequently pedunculated. Myxomas are important clinically because one-half present with thromboembolism, felt to be the result of embolization of tumor material itself or of overlying thrombi. Multiple myxomas may be present in the uncommon familial myxoma syndrome.",
"   </p>",
"   <p>",
"    Both TTE and TEE are highly sensitive in detecting myxomas (",
"    <a class=\"graphic graphic_movie graphicRef53539 \" href=\"UTD.htm?29/30/30178\">",
"     movie 19",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef58730 \" href=\"UTD.htm?39/46/40673\">",
"     movie 20",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef71550 \" href=\"UTD.htm?28/31/29171\">",
"     movie 21",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef53680 \" href=\"UTD.htm?2/22/2402\">",
"     movie 22",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef64739 \" href=\"UTD.htm?34/44/35522\">",
"     movie 23",
"    </a>",
"    ). TEE may provide more accurate anatomical details, such as the site of attachment, and, in selected patients, may help to differentiate these tumors from thrombi [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another histologically benign tumor associated with emboli is a cardiac papillary fibroelastoma. These tumors are usually pedunculated and most frequently located on the aortic or mitral valves, although they may also be present on endocardial surfaces [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/50\">",
"     50",
"    </a>",
"    ]. Echocardiographically, papillary fibroelastomas appear speckled with echolucencies near the edges [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/51\">",
"     51",
"    </a>",
"    ]. These tumors classically are not associated with valvular dysfunction, but they may be a source of systemic embolization due to migration of thrombus from the tumor surface [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/51\">",
"     51",
"    </a>",
"    ] or tumor embolization [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/52\">",
"     52",
"    </a>",
"    ]. They are best detected by TEE [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/32/17930?source=see_link&amp;anchor=H18#H18\">",
"     \"Cardiac tumors\", section on 'Papillary fibroelastomas'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Mitral annular calcification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common TTE finding among elderly patients referred for a cardiac source of embolism is mitral annular calcification which can often be seen on chest x-ray (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65536 \" href=\"UTD.htm?36/13/37076\">",
"     image 2",
"    </a>",
"    ) but is best detected by echocardiography (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61639 \" href=\"UTD.htm?21/38/22112\">",
"     image 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. Mitral annular calcification and its association with stroke are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/58/37801?source=see_link\">",
"     \"Mitral annular calcification\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Valve excrescences",
"    </span>",
"    &nbsp;&mdash;&nbsp;Valve excrescences are thin and elongated echoreflective structures with independent undulating hypermobility seen near the leaflet's line of closure. Also referred to as Lambl excrescences, they occur on the atrial side of the mitral and tricuspid valves, and the ventricular side of the aortic valve. Valve excrescences do not appear to be a primary source of cardioembolism [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Right heart thrombi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Right heart thrombi may develop in situ as a result of blood stagnation in patients with a cardiomyopathy or with a foreign body (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51650 \" href=\"UTD.htm?20/45/21214\">",
"     image 4",
"    </a>",
"    ). The prognosis is good with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    therapy. In contrast, floating right heart thrombi are uncommon and are in transit from the legs to the pulmonary artery. They can embolize at any time and are associated with a high mortality, requiring emergency surgery or thrombolytic therapy. In one study of 38 patients, a massive pulmonary embolism was documented in 37. Irrespective of therapy chosen, the in-hospital mortality was 45 percent, although the outcome after discharge was good (86 percent survival at 47 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;While multiple potential cardiac sources for embolism can be identified by transthoracic echocardiography (TTE), the use of this procedure among patients with unexplained stroke has come into question [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/57\">",
"     57",
"    </a>",
"    ]. In an unselected population, for example, the prevalence of a highly probable source of embolism was only 3 to 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/2,57\">",
"     2,57",
"    </a>",
"    ]. As might be expected, the yield is highest if the clinical history and examination suggests a cardiac source (as with atrial fibrillation, rheumatic mitral stenosis, diffuse atherosclerosis, left ventricular aneurysm, or clinical endocarditis).",
"   </p>",
"   <p>",
"    Aside from identification of apical left ventricular thrombi and mitral annular calcification in the elderly, transesophageal echocardiography (TEE) is superior to TTE for the other disorders described above. The corresponding yield of a cardiac source with TEE has been reported at 57 to 65 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/2,58\">",
"     2,58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the improved diagnostic yield, the therapeutic impact of TEE among patients with a suspected cardiac source of embolism remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12361/abstract/59\">",
"     59",
"    </a>",
"    ]. Several multicenter randomized trials are currently underway evaluating the efficacy of TEE in patients with cryptogenic stroke or transient ischemic attack. Until the results of these studies are known, it does not appear that routine TEE is warranted in this group unless the history or physical examination is suggestive of a cardiac source, and the treatment plan would be modified based upon the TEE results.",
"   </p>",
"   <p>",
"    TTE should be a part of the evaluation of the following categories of patients with suspected cardiac source of embolism:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients of any age with an abrupt occlusion of a major peripheral or visceral artery",
"     </li>",
"     <li>",
"      Patients &lt;55 years old with a cerebrovascular embolic event",
"     </li>",
"     <li>",
"      Patients &gt;55 years old with a neurologic event who have no other evidence of cerebrovascular disease",
"     </li>",
"     <li>",
"      Any patient in whom clinical therapy would be altered by the echocardiographic results",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When echocardiography is performed in a patient with a possible cardiac source of embolus, the study should include the administration of agitated saline contrast at rest, with cough, and with Valsalva maneuver to improve the detection of intracardiac shunting related to a patent foramen ovale.",
"   </p>",
"   <p>",
"    TEE should be performed in the evaluation of patients with suspected cardiac source of embolism in the following instances:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Following TTE if the TTE images are suboptimal.",
"     </li>",
"     <li>",
"      As the initial study if there is a moderate to high pretest likelihood of a cardiac embolic source (eg, younger patients and those with symptom onset in the setting of a deep venous thrombosis or elevated right atrial pressure).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/1\">",
"      Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. Arch Neurol 1989; 46:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/2\">",
"      Pearson AC, Labovitz AJ, Tatineni S, Gomez CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 1991; 17:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/3\">",
"      DeRook FA, Comess KA, Albers GW, Popp RL. Transesophageal echocardiography in the evaluation of stroke. Ann Intern Med 1992; 117:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/4\">",
"      McNamara RL, Lima JA, Whelton PK, Powe NR. Echocardiographic identification of cardiovascular sources of emboli to guide clinical management of stroke: a cost-effectiveness analysis. Ann Intern Med 1997; 127:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/5\">",
"      Rauh R, Fischereder M, Spengel FA. Transesophageal echocardiography in patients with focal cerebral ischemia of unknown cause. Stroke 1996; 27:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/6\">",
"      Daniel WG, M&uuml;gge A. Transesophageal echocardiography. N Engl J Med 1995; 332:1268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/7\">",
"      Khandheria BK, Seward JB, Tajik AJ. Transesophageal echocardiography. Mayo Clin Proc 1994; 69:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/8\">",
"      Leung DY, Davidson PM, Cranney GB, Walsh WF. Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiogram. Am J Cardiol 1997; 79:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/9\">",
"      Omran H, Rang B, Schmidt H, et al. Incidence of left atrial thrombi in patients in sinus rhythm and with a recent neurologic deficit. Am Heart J 2000; 140:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/10\">",
"      Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 1995; 25:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/11\">",
"      Manning WJ, Silverman DI, Waksmonski CA, et al. Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation. Arch Intern Med 1995; 155:2193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/12\">",
"      Manning WJ, Weintraub RM, Waksmonski CA, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med 1995; 123:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/13\">",
"      Lapeyre AC 3rd, Steele PM, Kazmier FJ, et al. Systemic embolism in chronic left ventricular aneurysm: incidence and the role of anticoagulation. J Am Coll Cardiol 1985; 6:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/14\">",
"      Vigna C, Russo A, De Rito V, et al. Frequency of left atrial thrombi by transesophageal echocardiography in idiopathic and in ischemic dilated cardiomyopathy. Am J Cardiol 1992; 70:1500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/15\">",
"      Black IW, Chesterman CN, Hopkins AP, et al. Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol 1993; 21:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/16\">",
"      Daniel WG, Nellessen U, Schr&ouml;der E, et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol 1988; 11:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/17\">",
"      Sadanandan S, Sherrid MV. Clinical and echocardiographic characteristics of left atrial spontaneous echo contrast in sinus rhythm. J Am Coll Cardiol 2000; 35:1932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/18\">",
"      Ileri M, B&uuml;y&uuml;ka��ik Y, Ileri NS, et al. Activation of blood coagulation in patients with mitral stenosis and sinus rhythm. Am J Cardiol 1998; 81:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/19\">",
"      Peverill RE, Gelman J, Harper RW, Smolich JJ. Stability of left atrial spontaneous echo contrast at repeat transesophageal echocardiography in patients with mitral stenosis. Am J Cardiol 1997; 79:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/20\">",
"      Tsai LM, Chen JH, Lin LJ, Teng JK. Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol 1997; 80:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/21\">",
"      Black IW, Hopkins AP, Lee LC, Walsh WF. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol 1991; 18:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/22\">",
"      Fatkin D, Loupas T, Low J, Feneley M. Inhibition of red cell aggregation prevents spontaneous echocardiographic contrast formation in human blood. Circulation 1997; 96:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/23\">",
"      Peverill RE, Harper RW, Gelman J, et al. Determinants of increased regional left atrial coagulation activity in patients with mitral stenosis. Circulation 1996; 94:331.",
"     </a>",
"    </li>",
"    <li>",
"     Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline for the clinical application of echocardiography www.acc.org/qualityandscience/clinical/statements.htm (Accessed on August 24, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/25\">",
"      Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/26\">",
"      Konstantinides S, Kasper W, Geibel A, et al. Detection of left-to-right shunt in atrial septal defect by negative contrast echocardiography: a comparison of transthoracic and transesophageal approach. Am Heart J 1993; 126:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/27\">",
"      Marriott K, Manins V, Forshaw A, et al. Detection of right-to-left atrial communication using agitated saline contrast imaging: experience with 1162 patients and recommendations for echocardiography. J Am Soc Echocardiogr 2013; 26:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/28\">",
"      Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/29\">",
"      Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318:1148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/30\">",
"      Di Tullio M, Sacco RL, Gopal A, et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992; 117:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/31\">",
"      Jones EF, Calafiore P, Donnan GA, Tonkin AM. Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly. Am J Cardiol 1994; 74:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/32\">",
"      Lethen H, Flachskampf FA, Schneider R, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 1997; 80:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/33\">",
"      St&ouml;llberger C, Slany J, Schuster I, et al. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 1993; 119:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/34\">",
"      Hausmann D, M&uuml;gge A, Daniel WG. Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol 1995; 26:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/35\">",
"      Ilercil A, Meisner JS, Vijayaraman P, et al. Clinical significance of fossa ovalis membrane aneurysm in adults with cardioembolic cerebral ischemia. Am J Cardiol 1997; 80:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/36\">",
"      Belkin RN, Hurwitz BJ, Kisslo J. Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events. Stroke 1987; 18:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/37\">",
"      Schneider B, Hanrath P, Vogel P, Meinertz T. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol 1990; 16:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/38\">",
"      Burger AJ, Sherman HB, Charlamb MJ. Low incidence of embolic strokes with atrial septal aneurysms: A prospective, long-term study. Am Heart J 2000; 139:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/39\">",
"      Zabalgoitia-Reyes M, Herrera C, Gandhi DK, et al. A possible mechanism for neurologic ischemic events in patients with atrial septal aneurysm. Am J Cardiol 1990; 66:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/40\">",
"      Silver MD, Dorsey JS. Aneurysms of the septum primum in adults. Arch Pathol Lab Med 1978; 102:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/41\">",
"      Erbel R, Rohmann S, Drexler M, et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur Heart J 1988; 9:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/42\">",
"      Shively BK, Gurule FT, Roldan CA, et al. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 1991; 18:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/43\">",
"      Di Salvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001; 37:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/44\">",
"      Lee RJ, Bartzokis T, Yeoh TK, et al. Enhanced detection of intracardiac sources of cerebral emboli by transesophageal echocardiography. Stroke 1991; 22:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/45\">",
"      Orsinelli DA, Pearson AC. Detection of prosthetic valve strands by transesophageal echocardiography: clinical significance in patients with suspected cardiac source of embolism. J Am Coll Cardiol 1995; 26:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/46\">",
"      Freedberg RS, Goodkin GM, Perez JL, et al. Valve strands are strongly associated with systemic embolization: a transesophageal echocardiographic study. J Am Coll Cardiol 1995; 26:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/47\">",
"      De Castro S, Magni G, Beni S, et al. Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am J Cardiol 1997; 80:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/48\">",
"      Dutta T, Karas MG, Segal AZ, Kizer JR. Yield of transesophageal echocardiography for nonbacterial thrombotic endocarditis and other cardiac sources of embolism in cancer patients with cerebral ischemia. Am J Cardiol 2006; 97:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/49\">",
"      Wold LE, Lie JT. Cardiac myxomas: a clinicopathologic profile. Am J Pathol 1980; 101:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/50\">",
"      Sun JP, Asher CR, Yang XS, et al. Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation 2001; 103:2687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/51\">",
"      Klarich KW, Enriquez-Sarano M, Gura GM, et al. Papillary fibroelastoma: echocardiographic characteristics for diagnosis and pathologic correlation. J Am Coll Cardiol 1997; 30:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/52\">",
"      Edwards FH, Hale D, Cohen A, et al. Primary cardiac valve tumors. Ann Thorac Surg 1991; 52:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/53\">",
"      Aronow WS, Koenigsberg M, Kronzon I, Gutstein H. Association of mitral anular calcium with new thromboembolic stroke and cardiac events at 39-month follow-up in elderly patients. Am J Cardiol 1990; 65:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/54\">",
"      Benjamin EJ, Plehn JF, D'Agostino RB, et al. Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med 1992; 327:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/55\">",
"      Roldan CA, Shively BK, Crawford MH. Valve excrescences: prevalence, evolution and risk for cardioembolism. J Am Coll Cardiol 1997; 30:1308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/56\">",
"      Chartier L, B&eacute;ra J, Delomez M, et al. Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation 1999; 99:2779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/57\">",
"      Sansoy V, Abbott RD, Jayaweera AR, Kaul S. Low yield of transthoracic echocardiography for cardiac source of embolism. Am J Cardiol 1995; 75:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/58\">",
"      Daniel WG, Angermann C, Engberding R, et al. Transesophageal echocardiography in patients with cerebral ischemic events and arterial embolism &mdash; a European multicenter study (abstract). Circulation 1989; 80:II473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12361/abstract/59\">",
"      Hata JS, Ayres RW, Biller J, et al. Impact of transesophageal echocardiography on the anticoagulation management of patients admitted with focal cerebral ischemia. Am J Cardiol 1993; 72:707.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5303 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.69.132.100-7288C09AE7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12361=[""].join("\n");
var outline_f12_4_12361=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MAJOR SOURCES OF EMBOLI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Left atrial thrombi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Left atrial spontaneous echo contrast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Aortic atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Left ventricular thrombi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Prosthetic valve thrombi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Abnormalities of the interatrial septum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Interatrial shunt",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Atrial septal aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LESS COMMON CARDIAC SOURCES OF EMBOLI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Nonbacterial thrombotic endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Intracardiac tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Mitral annular calcification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Valve excrescences",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Right heart thrombi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/5303\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5303|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/50/18223\" title=\"diagnostic image 1\">",
"      Spontaneous echo contrast seen in the left atrium on TEE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/13/37076\" title=\"diagnostic image 2\">",
"      Mitral annular calcium PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/38/22112\" title=\"diagnostic image 3\">",
"      Apical 4 chamber Ca MV annulus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/45/21214\" title=\"diagnostic image 4\">",
"      Right atrial thrombus venogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5303|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/45/15071\" title=\"figure 1\">",
"      Left atrial thrombus AF Echo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5303|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?25/10/25775\" title=\"movie 1\">",
"      TEE LA thrombus and spontaneous echo contrast 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?10/61/11231\" title=\"movie 2\">",
"      TEE LA thrombus and spontaneous echo contrast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?23/51/24383\" title=\"movie 3\">",
"      TEE LA appendage thrombus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?4/61/5072\" title=\"movie 4\">",
"      TEE left atrial appendage thrombus and spontaneous echo contrast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?4/11/4287\" title=\"movie 5\">",
"      TEE LAA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?18/15/18686\" title=\"movie 6\">",
"      TEE aortic plaque",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?5/46/5871\" title=\"movie 7\">",
"      Left ventricular thrombus five chamber echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?30/38/31343\" title=\"movie 8\">",
"      TEE LA and prosthetic MV thrombus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?24/40/25231\" title=\"movie 9\">",
"      TEE IAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?15/10/15524\" title=\"movie 10\">",
"      TTE 4Ch IAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?6/56/7040\" title=\"movie 11\">",
"      TTE two ASDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?22/39/23167\" title=\"movie 12\">",
"      TEE ASD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?12/48/13057\" title=\"movie 13\">",
"      TEE PFO",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?32/20/33094\" title=\"movie 14\">",
"      TEE PFO with contrast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?8/49/8983\" title=\"movie 15\">",
"      TEE contrast atrial septal aneurysm and defect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?22/46/23279\" title=\"movie 16\">",
"      TEE 4 chamber view tricuspid valve vegetation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?30/9/30867\" title=\"movie 17\">",
"      Parasternal long axis echo aortic valve vegetation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?29/38/30306\" title=\"movie 18\">",
"      TEE mitral valve aneurysm from endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?29/30/30178\" title=\"movie 19\">",
"      Left atrial myxoma 4 chamber view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?39/46/40673\" title=\"movie 20\">",
"      Left atrial myxoma five chamber echocardiogram 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?28/31/29171\" title=\"movie 21\">",
"      Left atrial myxoma five chamber echocardiogram 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?2/22/2402\" title=\"movie 22\">",
"      TEE left atrial myxoma 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?34/44/35522\" title=\"movie 23\">",
"      TEE left atrial myxoma 2",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/11/18618?source=related_link\">",
"      Antithrombotic therapy in patients with prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=related_link\">",
"      Antithrombotic therapy to prevent embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39689?source=related_link\">",
"      Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/32/17930?source=related_link\">",
"      Cardiac tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25497?source=related_link\">",
"      Complications of prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/10/40105?source=related_link\">",
"      Cryptogenic stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10809?source=related_link\">",
"      Embolism from aortic plaque: Thromboembolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/15/31994?source=related_link\">",
"      Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=related_link\">",
"      Hypercoagulable disorders associated with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7048?source=related_link\">",
"      Indications for antithrombotic therapy in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/23/31094?source=related_link\">",
"      Infective endocarditis: Historical and Duke criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5497?source=related_link\">",
"      Left ventricular thrombus after acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/58/37801?source=related_link\">",
"      Mitral annular calcification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/32/3593?source=related_link\">",
"      Patent foramen ovale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38280?source=related_link\">",
"      Transesophageal echocardiography: Indications, complications, and normal views",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_4_12362="Pathology of head and neck neoplasms";
var content_f12_4_12362=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathology of head and neck neoplasms",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12362/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12362/contributors\">",
"     G Kenneth Haines, III, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12362/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12362/contributors\">",
"     Bruce E Brockstein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/4/12362/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/4/12362/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/4/12362/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cancer of the head and neck refers to a collection of cancers, predominantly squamous cell carcinoma, arising from a variety of sites and grouped together under this category. The pathology of malignant neoplasms presenting in the head and neck will be reviewed here, with a focus on recent advances and continuing controversies involving the pathobiology of head and neck neoplasia. By necessity, this discussion will not be exhaustive. Several subspecialty textbooks on head and neck pathology are excellent sources for a more comprehensive coverage of head and neck neoplasms [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NONINVASIVE SQUAMOUS EPITHELIAL LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Within the squamous mucosa that lines many of the structures of the head and neck, several noninvasive lesions may develop. Transformation of clonally independent premalignant lesions is thought to progress in a multistep fashion through hyperplasia and dysplasia to in situ and invasive carcinoma.",
"   </p>",
"   <p>",
"    Leukoplakia, erythroplakia, and leukoerythroplakia are clinical terms meaning white, red, or speckled mucosal plaques, respectively, but do not denote a specific pathologic entity. These require biopsy for pathologic diagnosis, as they have different rates of harboring or converting to invasive cancer. Most, but not all, leukoplakic lesions are benign. If there is no associated dysplasia, then the chance of finding invasive cancer is about 3 percent, but if dysplasia is present, about 10 percent of leukoplakic lesions have an invasive component. Erythroplakia more frequently harbors carcinoma in situ, and invasive carcinoma is detected in about 30 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34825?source=see_link\">",
"     \"Head and neck squamous cell carcinogenesis: Molecular and genetic alterations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SQUAMOUS HYPERPLASIA AND DYSPLASIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathologic evaluation of oral epithelial dysplasia remains an inexact science, with some authors reporting that dysplasia on biopsy or resection is not predictive of subsequent malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. There is a wide degree of inter- and intra-observer variability in grading oral epithelial dysplasia. Attempts at improving reliability and standardization are ongoing. Following the 2005 World Health Organization (WHO) Classification, squamous precursor and related lesions can be categorized as hyperplasia, mild, moderate, or severe dysplasia, or carcinoma in situ (",
"    <a class=\"graphic graphic_table graphicRef59087 \" href=\"UTD.htm?7/1/7196\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Squamous hyperplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Squamous hyperplasia encompasses both acanthosis (increased thickness of the spinous layers) and basal cell hyperplasia (increase in the layers of",
"    <span class=\"nowrap\">",
"     basal/parabasal",
"    </span>",
"    cells). The later may at times be difficult to distinguish from mild dysplasia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Squamous dysplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Under the WHO system, abnormal architectural and cytological features largely confined to the lower third of the epithelium define mild dysplasia. Cytological atypia must be present, but is not marked. In moderate dysplasia, the dysplastic process extends into the middle third of the epithelium, with the caveat that marked cytological atypia warrants classification as severe dysplasia. Extension of the process into the upper third of the epithelium qualifies as severe dysplasia. Carcinoma in situ is defined by full thickness involvement in the absence of invasion; there is often marked cytological atypia as well.",
"   </p>",
"   <p>",
"    Use of WHO architectural and cytologic criteria appears to improve the rate of inter-observer agreement in classifying oral epithelial dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Two-tiered systems may also predict clinical outcomes. Based upon an initial pilot study, the WHO criteria (",
"    <a class=\"graphic graphic_table graphicRef59087 \" href=\"UTD.htm?7/1/7196\">",
"     table 1",
"    </a>",
"    ) were used to define low- and high-risk dysplasia: high-risk lesions showed four or more of the seven WHO architectural features and five or more of the nine cytologic features [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/8\">",
"     8",
"    </a>",
"    ]. Low-risk lesions were associated with less than four architectural or less than five cytological changes. In a subsequent retrospective study, in which biopsy specimens were reclassified and compared to known clinical outcomes, this system was able to predict malignant transformation with a sensitivity of 85 percent and specificity of 80 percent.",
"   </p>",
"   <p>",
"    Another issue to consider in the evaluation of premalignant epithelial lesions is the variable degrees of dysplasia within the lesion. A report comparing biopsy with subsequent resection specimens noted that the degree of dysplasia was underestimated in a third of cases and carcinoma was missed in 7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reported rate of progression from dysplasia to invasive carcinoma varies widely. However, more recently reported progression rates of 3 to 12 percent suggests that close clinical follow up of all premalignant lesions be mandated [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/4,9\">",
"     4,9",
"    </a>",
"    ]. Given the current limitations of histopathology to predict malignant transformation, there is a great need for the identification of biomarkers to define risk groups.",
"   </p>",
"   <p>",
"    Descriptions of chromosomal alterations and identification of affected molecular pathways are driving our understanding of head and neck carcinogenesis. Using comparative genomic hybridization (CGH) to analyze genetic alterations, some have reported a gain of 8q22-23 as the earliest event in oral carcinogenesis, with the number of DNA sequence copy number aberrations (DSCNAs) increasing in parallel to the degree of dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/10\">",
"     10",
"    </a>",
"    ]. Homeobox (HOX) genes are important in embryonic morphogenesis and play a role in maintaining architectural integrity in some adult tissues. It has been suggested that dysregulation of a subset of these genes (HOXA2, A3, B3 and D10) may be the molecular basis for the architectural disorder characteristic of oral epithelial dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many additional defects have been described at the molecular level in head and neck carcinogenesis. These include derangements involving cell-cell and epithelial-stromal interactions, regulators of cell proliferation and apoptosis, and internal signaling pathways. Efforts to translate this new level of understanding at the molecular level into clinical practice are ongoing. As an example, some have shown that the pattern of Ki-67 reactivity can distinguish normal squamous mucosa from hyperplasia; EGFR, Stat3, p16 and c-myc are useful in distinguishing hyperplasia from dysplasia; and Rb and p53 immunostains can separate dysplasia from early stage carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/12\">",
"     12",
"    </a>",
"    ]. Confirmation in a large-scale multi-center setting is needed before such findings make their way into routine clinical practice. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34825?source=see_link\">",
"     \"Head and neck squamous cell carcinogenesis: Molecular and genetic alterations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Others have demonstrated that alcohol and tobacco alter the pattern of cellular differentiation in oral mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INVASIVE SQUAMOUS CELL CARCINOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gross and histologic features of squamous cell carcinoma (SCC) involving the head and neck are similar to those found elsewhere in the body.",
"   </p>",
"   <p>",
"    Based upon how closely tumors resemble normal squamous epithelium, they are graded as well- (",
"    <a class=\"graphic graphic_picture graphicRef78595 \" href=\"UTD.htm?2/46/2790\">",
"     picture 1",
"    </a>",
"    ), moderately- (",
"    <a class=\"graphic graphic_picture graphicRef78301 \" href=\"UTD.htm?42/32/43525\">",
"     picture 2",
"    </a>",
"    ) or poorly-differentiated carcinomas (",
"    <a class=\"graphic graphic_picture graphicRef63428 \" href=\"UTD.htm?13/50/14119\">",
"     picture 3",
"    </a>",
"    ). While keratinization, the thick surface keratin layer formed from whorls (pearls) of keratin within tumor nests, is more common in well-differentiated cancers, it may be found in tumors of any grade. It is therefore not used as a basis for grading squamous carcinomas.",
"   </p>",
"   <p>",
"    Carcinomas arising from the oral cavity most frequently are well to moderately differentiated, while those from the base of tongue, hypopharynx and tonsillar crypts are typically poorly differentiated. As currently practiced, histologic grading is of limited value in predicting clinical outcomes for head and neck cancer patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Histologic and molecular prognostic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The size of the cancer and the presence or absence of nodal metastasis remain the major prognostic determinants in head and neck squamous cell carcinoma. However, additional prognostic information may be gleaned from evaluation of routine histologic sections:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tumor thickness is related to risk of nodal metastases in oral tongue carcinoma [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tumors with a broad or pushing invasive front are prognostically favorable, compared to tumors that infiltrate as irregular nests or individual cells [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/6,15\">",
"       6,15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Invasion of lymphatic vessels increases the risk of regional or distant metastasis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The rate of recurrence is increased when invasive or pre-invasive tumor is present at the surgical resection margin [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/16,17\">",
"       16,17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Examination of molecular markers may provide additional prognostic information, as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preliminary studies suggest that there may be a particular gene expression profile that identifies metastatic potential in oral squamous cell carcinoma [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intraoperative detection of tumor-specific molecular alterations in histologically unremarkable surgical resection margins is correlated with a greater risk of local recurrence [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Presence of TP3 mutations and expression of angiogenic factors or certain metalloproteinases have been associated with nodal metastasis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      poorer survival [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/20-23\">",
"       20-23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A different set of molecular and genetic abnormalities may underlie oral cancers in younger patients, particularly non-smokers [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These results suggest that, in the future, molecular staging may prove to be more predictive of outcome than current staging systems that are based upon radiologic and histologic observations. However, molecular staging is not accepted as current standard of practice. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34825?source=see_link\">",
"     \"Head and neck squamous cell carcinogenesis: Molecular and genetic alterations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36537?source=see_link\">",
"     \"Overview of the diagnosis and staging of head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A minority of tumors have distinct architectural and histologic features that merit distinction on account of well-documented differences in behavior. These include verrucous, basaloid, and spindle cell variants of SCC, as well as nasopharyngeal carcinoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Verrucous carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Verrucous carcinoma (VC) comprises less than 5 percent of carcinomas. It is an indolent tumor which is most often seen in elderly patients with or without a smoking history [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/25\">",
"     25",
"    </a>",
"    ]. Although HPV has been implicated as an etiologic factor, the appearance of VC is not typical of the more common oropharyngeal human papilloma virus (HPV) associated squamous carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The verrucous lesion presents as a velvety or warty exophytic malignant-appearing mass (",
"    <a class=\"graphic graphic_picture graphicRef57350 \" href=\"UTD.htm?19/25/19856\">",
"     picture 4",
"    </a>",
"    ). In contrast to the clinical appearance, the histology is bland. Blunt finger-like epithelial projections extend into the lamina propria and are associated with a brisk lymphocytic inflammatory response (",
"    <a class=\"graphic graphic_picture graphicRef70135 \" href=\"UTD.htm?30/50/31524\">",
"     picture 5",
"    </a>",
"    ). The superficial portion of the lesion may appear benign, necessitating a deep biopsy for histologic examination of the base of the lesion. Even with appropriate sampling, the differentiation of VC from a hyperplastic process or conventional SCC is often difficult. In fact, areas of high-grade SCC may be harbored within VC. It is the highest grade component that determines the prognosis for the patient.",
"   </p>",
"   <p>",
"    Ancillary studies may be helpful in indeterminate cases. In one study, immunohistochemical expression of Ki67, a proliferation marker, and p53, a mutated tumor suppressor gene, was limited to the basal layer in hyperplasia, involved the lower one-third of the epithelium in VC, and was present full-thickness in squamous cell carcinomas [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In pure form, VCs rarely metastasize, and although they demonstrate progressive local growth, they have an extremely favorable prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/28\">",
"     28",
"    </a>",
"    ]. Differences in expression of matrix metalloproteinases may partially explain the less aggressive behavior of VCs, as compared to conventional SCC [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complete surgical excision is the primary therapy for these lesions. Although VCs may not respond as well as typical SCCs to radiation therapy (RT), outcomes comparable to surgery have been reported with initial RT [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/30\">",
"     30",
"    </a>",
"    ]. Previously, it was suggested that RT may cause conversion of VC lesions considered relatively indolent to more poorly differentiated SCCs. However, it has been subsequently recognized that the more aggressive invasive SCC was simply not appreciated at the time of VC diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/31\">",
"     31",
"    </a>",
"    ]. Response to oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    , topical 5-aminolevulinic acid-mediated photodynamic therapy, and intraarterial",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    infusion have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/32-34\">",
"     32-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to these well-differentiated lesions, verrucoid squamous cell carcinoma, which has hybrid features, behaves like conventional SCCs and should be treated accordingly. These lesions were previously attributed to dedifferentiation (a conventional SCC arising from a verrucous carcinoma) following RT. It is now well documented that these hybrid tumors arise de novo and are unrelated to radiation therapy.",
"   </p>",
"   <p>",
"    A spectrum of noninvasive mucosal lesions with a verrucoid appearance is described in the oral cavity. Although there is no distinct histologic demarcation, the most benign is isolated verrucoid hyperplasia (VH, (",
"    <a class=\"graphic graphic_picture graphicRef79465 \" href=\"UTD.htm?1/44/1731\">",
"     picture 6",
"    </a>",
"    )). At the other end of the spectrum is proliferative verrucous leukoplakia (PVL), an aggressive variant marked by local extension, frequent recurrences, and progression to verrucous or conventional squamous carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Overexpression of c-erbB-3 may play a role in progression to invasive carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Basaloid SCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Basaloid SCCs are poorly differentiated SCCs which exhibit lobular to solid infiltration of basaloid cells. They have been correlated with HPV positivity (HPV 16) and are likely to arise from the tonsil or base of the tongue [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/27,38\">",
"     27,38",
"    </a>",
"    ]. They tend to metastasize to regional nodes at earlier T-stage, so patients present with more advanced stage disease, typically stage III or IV. Relatively high rates of distant metastases, predominately lung, have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/39\">",
"     39",
"    </a>",
"    ]. Nonetheless, clinical studies indicate that these tumors respond perhaps better than conventional SCCs to RT and chemotherapy, so that the prognosis is better stage for stage for these basaloid tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/38-40\">",
"     38-40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Grossly, these tumors appear as firm white masses, often with central necrosis. Histologically, they are highly infiltrative tumors composed of small basaloid cells with hyperchromatic nuclei, frequent mitoses, and scant cytoplasm, arranged as solid nests, cords, or cystic masses (",
"    <a class=\"graphic graphic_picture graphicRef80505 \" href=\"UTD.htm?3/46/3817\">",
"     picture 7",
"    </a>",
"    ). Foci of conventional SCC (in situ or invasive) can often be identified within or adjacent to the tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Spindle cell SCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spindle and sarcomatoid variants are rare, poorly differentiated forms of SCC that should not be confused with sarcomas. Although spindle cell SCC may be found at any site within the head and neck, the most common sites are larynx and oral cavity.",
"   </p>",
"   <p>",
"    Grossly, these tumors may present as smooth polypoid nodules, fungating masses, or flat ulcers. Microscopically, the characteristic spindle-shaped cells have a variable degree of cytologic atypia, and the growth pattern is one of interlacing fascicles or pinwheel (storiform) arrangements (",
"    <a class=\"graphic graphic_picture graphicRef58508 \" href=\"UTD.htm?34/57/35737\">",
"     picture 8",
"    </a>",
"    ). The histologic differential often includes other spindle cell lesions such as sarcoma,",
"    <span class=\"nowrap\">",
"     desmoplastic/spindle",
"    </span>",
"    cell carcinoma, or melanoma. The recognition of foci of conventional SCC (in situ or invasive) is helpful in identification. However, squamous mucosa can show alarming reactive cytologic changes secondary to infiltration by an underlying tumor. Immunohistochemical stains for cytokeratin (CK) and vimentin (Vim) are often helpful as they can demonstrate populations of epithelial (CK+Vim-), mesenchymal (CK-Vim+), and intermediate cells (CK+Vim+) within the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spindle cell carcinomas are characterized by aggressive behavior, with high rates of locoregional recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/42\">",
"     42",
"    </a>",
"    ]. Prognosis has been associated with tumor location, tumor size and stage, depth of invasion, and presence of keratin staining in the spindle cells [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. A literature only consisting of case series supports the role of surgery as primary therapy; some, but not all, have found these tumors to be relatively radioresistant [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/43,44\">",
"     43,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Nasopharyngeal carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasopharyngeal carcinoma originates from the surface epithelium of the nasopharynx. The WHO classifies nasopharyngeal carcinoma into two main types: keratinizing squamous cell carcinoma and non-keratinizing carcinoma.",
"   </p>",
"   <p>",
"    Keratinizing squamous cell carcinoma accounts for one-quarter of nasopharyngeal carcinomas in the United States, compared to 1 percent or fewer in Hong Kong [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/6\">",
"     6",
"    </a>",
"    ]. Outside of endemic areas, it has a weak association with Epstein-Barr virus (EBV). Some, but not all studies suggest that this form may not be as radioresponsive as undifferentiated, nonkeratinizing nasopharyngeal carcinoma and may have a somewhat poorer five-year survival rate.",
"   </p>",
"   <p>",
"    Nonkeratinizing carcinoma accounts for 75 percent of nasopharyngeal carcinomas in the US compared to 99 percent in Hong Kong [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/6\">",
"     6",
"    </a>",
"    ]. It is strongly associated with EBV. These tumors may be divided into differentiated (resembling non-keratinizing squamous or transitional cell carcinoma) and undifferentiated carcinoma, but such a division has no clinical significance. They generally induce a marked infiltration of benign T-lymphocytes around and within the tumor, hence the older term \"lymphoepithelioma\" (",
"    <a class=\"graphic graphic_picture graphicRef73439 \" href=\"UTD.htm?40/21/41304\">",
"     picture 9",
"    </a>",
"    ). Nonkeratinizing nasopharyngeal carcinomas are radiosensitive and achieve good local control with RT, but nodal and distant metastases may occur earlier than with keratinizing nasopharyngeal carcinomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/36/26184?source=see_link\">",
"     \"Epidemiology, etiology, and diagnosis of nasopharyngeal carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nonkeratinizing nasopharyngeal carcinomas are characterized by a dense lymphoplasmacellular infiltrate containing cohesive nests or scattered tumor cells. The neoplastic cells have large nuclei, prominent eosinophilic nucleoli, and scant cytoplasm. When growing in clusters, the cell borders are indistinct, thus giving a syncytial appearance.",
"   </p>",
"   <p>",
"    The interaction of EBV with other exogenous factors in nasopharyngeal carcinoma tumor development in a genetically susceptible individual is complex. Overexpression of EBER-1 and p53 and loss of cell cycle regulatory proteins p16 and p27 appear to occur at early stages of nasopharyngeal carcinogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/45\">",
"     45",
"    </a>",
"    ]. Disturbances in a number of signaling cascades, including activation of STAT3 and NF-kappaB, and inhibition of p38-MAPK and Wnt signaling pathways have all been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Others have noted that a combination of promoter hypermethylation and loss of heterozygosity of DLC-1, a proposed tumor suppressor gene, contribute to downregulation of this tumor suppressor [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     OTHER MUCOSAL EPITHELIAL TUMORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Schneiderian papillomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Schneiderian papillomas most often arise from the ectodermally derived mucosa of the nasal cavity and sinuses (Schneiderian epithelium). These polyps are divided into three categories:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fungiform (everted) papillomas arise from the nasal septum and have an exophytic growth pattern (",
"      <a class=\"graphic graphic_picture graphicRef61144 \" href=\"UTD.htm?0/59/946\">",
"       picture 10",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Inverted papillomas arise from the lateral nasal or sinus wall or paranasal sinuses and show an endophytic or mixed",
"      <span class=\"nowrap\">",
"       exophytic/endophytic",
"      </span>",
"      growth pattern. The lining in either consists of multilayered non-keratinized squamous epithelium with scattered mucous cells and microcysts filled with neutrophils (",
"      <a class=\"graphic graphic_picture graphicRef72164 \" href=\"UTD.htm?40/5/41047\">",
"       picture 11",
"      </a>",
"      ). These lesions have definite rates of conversion to or harboring of invasive SCC that requires adequate evaluation for diagnosis and treatment selection [",
"      <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/49\">",
"       49",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/44/23241?source=see_link&amp;anchor=H27#H27\">",
"       \"Paranasal sinus cancer\", section on 'Inverted papilloma'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Oncocytic Schneiderian papillomas, formerly known as cylindrical cell papillomas, arise from the lateral sinus wall or paranasal sinuses, and have a distinctive stratified lining of bright pink granular columnar cells with microcysts (",
"      <a class=\"graphic graphic_picture graphicRef77642 \" href=\"UTD.htm?6/31/6645\">",
"       picture 12",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Schneiderian papillomas must be distinguished from squamous papillomas, which consist of an arborizing fibrovascular core with a bland squamous epithelial lining (",
"    <a class=\"graphic graphic_picture graphicRef63595 \" href=\"UTD.htm?23/61/24530\">",
"     picture 13",
"    </a>",
"    ) and from sinonasal polyps, which represent localized outpouchings of the sinonasal mucosa due to edema (",
"    <a class=\"graphic graphic_picture graphicRef60614 \" href=\"UTD.htm?30/21/31061\">",
"     picture 14",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. In equivocal cases, increased proliferative activity as demonstrated by PCNA or Ki67 immunostaining may be useful in excluding a sino-nasal polyp [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Human papillomavirus (HPV) serotypes 6 and 11 are strongly associated with the fungiform papilloma, and to a lesser degree, with inverted papillomas [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/53\">",
"     53",
"    </a>",
"    ]. Both inverted and oncocytic Schneiderian papillomas carry an increased risk (5 to 10 percent) of subsequent or concurrent carcinoma, emphasizing the importance of wide excision and long-term follow-up for affected patients. In one series, recurrence was twice as frequent after resection of an oncocytic Schneiderian papilloma as compared to an inverted papilloma (2 of 6 compared to 5 of 34), but the risk of malignant behavior was similar [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Features associated with recurrence or malignant transformation include bone invasion, high grade dysplasia, increased mitotic activity, epithelial hyperplasia, and epithelial overgrowth of stroma. Favorable histologic features include the presence of inflammatory polyps and high eosinophil counts [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    External surgical approaches ranging from Caldwell-Luc to medial maxillectomy were introduced to reduce high local recurrence rates seen with traditional debulking procedures. However, reports show that acceptable control rates of about 85 percent can be achieved with less invasive endonasal endoscopic resections [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Long-term follow-up, however, is required, as the median time to recurrence can be nearly two years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Sinonasal undifferentiated carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sinonasal undifferentiated carcinoma (SNUC) is a poorly differentiated malignancy that arises from Schneiderian mucosa. These fast-growing tumors are composed of sheets, nests or trabeculi of pleomorphic cells with round to oval hyperchromatic nuclei, variably prominent nucleoli, and moderate eosinophilic cytoplasm (",
"    <a class=\"graphic graphic_picture graphicRef72367 \" href=\"UTD.htm?3/16/3335\">",
"     picture 15",
"    </a>",
"    ). Abundant mitotic activity and areas of necrosis are often seen. Immunohistochemically, a proportion of cases will demonstrate neuroendocrine differentiation, although others stain only for epithelial markers, for example, epithelial membrane antigen (EMA) and cytokeratin [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/46/12008?source=see_link&amp;anchor=H8#H8\">",
"     \"Olfactory neuroblastoma (esthesioneuroblastoma)\", section on 'Differential diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/44/23241?source=see_link&amp;anchor=H6304283#H6304283\">",
"     \"Paranasal sinus cancer\", section on 'Sinonasal undifferentiated carcinoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SINONASAL ADENOCARCINOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most head and neck adenocarcinomas arise from the salivary glands or from the sinonasal tract. These sinonasal tumors may resemble common salivary tumors, seromucinous tumors, tumors with enteric-type differentiation, or other rare variants [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/59\">",
"     59",
"    </a>",
"    ]. The seromucinous type adenocarcinomas range from low-grade tumors with fusion of glands composed of bland seromucinous cells to those with cystic or tubulo-papillary growth patterns (",
"    <a class=\"graphic graphic_picture graphicRef65748 \" href=\"UTD.htm?2/47/2808\">",
"     picture 16",
"    </a>",
"    ). Intestinal-type adenocarcinomas (ITAC) resemble metastatic carcinoma from the gastrointestinal tract. The immunohistochemical profile of cytokeratin (CK) 7+ and CK 20+, typically seen in ITAC, is distinct from colonic adenocarcinomas (CK7-, CK20+), but overlaps a proportion of rectal and other carcinomas (",
"    <a class=\"graphic graphic_picture graphicRef78080 \" href=\"UTD.htm?1/42/1702\">",
"     picture 17",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/60-62\">",
"     60-62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exposure to wood or leather dust is highly associated with ITAC arising in the ethmoid sinus, with such exposure reported in more than 90 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/63\">",
"     63",
"    </a>",
"    ]. The clinical behavior of these tumors is more closely related to tumor grade, although ITACs are reported to be more aggressive than seromucinous-type carcinomas [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/44/23241?source=see_link\">",
"     \"Paranasal sinus cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     OLFACTORY NEUROBLASTOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Olfactory neuroblastoma (ONB, esthesioneuroblastoma) is a rare tumor arising from neuroectodermal cells located in the roof of the nasal cavity and paranasal sinuses. The tumor is composed of small round cells arranged in lobules or sheets (",
"    <a class=\"graphic graphic_picture graphicRef50794 \" href=\"UTD.htm?3/37/3671\">",
"     picture 18",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/6\">",
"     6",
"    </a>",
"    ]. The stroma is typically pink, neurofibrillary or edematous, and well vascularized.",
"   </p>",
"   <p>",
"    Homer Wright pseudorosettes (tumor cells surrounding a central pink fibrillar material) are seen in one-half of ONBs; true (Flexner type) rosettes (tumor cells surrounding a central lumen) are infrequent. Necrosis, dystrophic calcification, and vascular or lymphatic invasion are not uncommon.",
"   </p>",
"   <p>",
"    The Hyams system grades tumors from I to IV based upon pathologic features such as mitotic activity and necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/66\">",
"     66",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Grade I tumors are characterized by a prominent fibrillary matrix, tumor cells with uniform nuclei and absence of nuclear pleomorphism, mitotic activity, or necrosis.",
"     </li>",
"     <li>",
"      Grade II tumors have some fibrillary matrix and exhibit moderate nuclear polymorphism with some mitotic activity. There is no necrosis.",
"     </li>",
"     <li>",
"      Grade III tumors have minimal fibrillary matrix and Flexner type rosettes are present. There is prominent mitotic activity and nuclear polymorphism and some necrosis may be seen.",
"     </li>",
"     <li>",
"      Grade IV tumors have no fibrillary matrix or rosettes and show marked nuclear pleomorphism and increased mitotic activity with frequent necrosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most series report good correlation of Hyams grade and stage with prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/46/12008?source=see_link\">",
"     \"Olfactory neuroblastoma (esthesioneuroblastoma)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SALIVARY GLAND TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Salivary gland tumors vary considerably in their histologic patterns and behavior. The variable contribution of luminal and abluminal cells, in conjunction with matrix production by the latter, produces a dazzling array of distinct patterns, even within the same tumor subtype (",
"    <a class=\"graphic graphic_table graphicRef70453 \" href=\"UTD.htm?20/36/21069\">",
"     table 2",
"    </a>",
"    ). Most salivary gland tumors are composed of more than one cell type. These can be divided into luminal (acinar and ductal) and abluminal (myoepithelial and basal) types with analogies to the composition of normal salivary glands. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=see_link\">",
"     \"Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/41/28313?source=see_link\">",
"     \"Salivary gland tumors: Treatment of locoregional disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Benign salivary gland tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign salivary gland tumors can be monomorphic or pleomorphic. The most common monomorphic adenoma is Warthin tumor (",
"    <a class=\"graphic graphic_picture graphicRef61792 \" href=\"UTD.htm?10/21/10584\">",
"     picture 19",
"    </a>",
"    ), followed by basal cell adenoma, canalicular adenoma, and myoepithelioma (",
"    <a class=\"graphic graphic_table graphicRef70453 \" href=\"UTD.htm?20/36/21069\">",
"     table 2",
"    </a>",
"    ). In contrast to pleomorphic adenomas, monomorphic adenomas show a distinct interface between the epithelial cells and stroma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Pleomorphic adenoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleomorphic adenomas (benign mixed tumor) contain groups of epithelial and myoepithelial cells in a chondromyxoid or hyalinized stroma. Close inspection shows that the border between epithelial nests and stromal cells is indistinct, as myoepithelial cells appear to drop off from the nests and merge with spindled stromal myoepithelial cells (",
"    <a class=\"graphic graphic_picture graphicRef57097 \" href=\"UTD.htm?42/33/43543\">",
"     picture 20",
"    </a>",
"    ). The different proportions of cell types (luminal and abluminal) and the variable amount and type of stroma give a wide variety of histologic appearances.",
"   </p>",
"   <p>",
"    Although most pleomorphic adenomas are encapsulated or at least circumscribed, simple enucleation of a pleomorphic adenoma arising in major salivary glands results in a high recurrence rate. Complete surgical excision with a rim of normal tissue greatly reduces such recurrences. Pleomorphic adenomas arising in minor salivary glands do not show this same propensity for recurrence, even when lacking a well-defined capsule.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H267154018\">",
"    <span class=\"h3\">",
"     Carcinoma ex pleomorphic adenoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally, a patient with a long history of a stable mass in a salivary gland notices sudden growth. Upon excision, a malignant tumor may be found to have arisen from a pleomorphic adenoma (",
"    <a class=\"graphic graphic_picture graphicRef71010 \" href=\"UTD.htm?0/14/233\">",
"     picture 21",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. The prognosis of a carcinoma arising within a pleomorphic adenoma is largely but not entirely dependent upon the extent of invasion. Cases where the carcinoma component was confined within the tumor capsule have not recurred or metastasized, in contrast to the aggressive behavior seen with invasive carcinoma ex pleomorphic adenoma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/71\">",
"     71",
"    </a>",
"    ]. Other prognostic factors include grade, tumor size, and lymph node status [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/72\">",
"     72",
"    </a>",
"    ]. Expression of p53 protein and c-erb-2 appear to be early events in malignant transformation in pleomorphic adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/73,74\">",
"     73,74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Frequent local recurrences and distant metastases mark the clinical course of invasive carcinoma ex pleomorphic adenoma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/75\">",
"     75",
"    </a>",
"    ]. Carcinoma ex pleomorphic adenoma should be considered a high-grade malignancy requiring adequately aggressive treatment at initial diagnosis, as subsequent salvage options are limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Malignant tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and proportion of malignant tumors and the array of histologic types of salivary gland tumors vary between major and minor salivary glands [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/76-79\">",
"     76-79",
"    </a>",
"    ]. Furthermore, there are large differences in the relative incidence in different geographic regions.",
"   </p>",
"   <p>",
"    Overall, mucoepidermoid carcinoma and adenoid cystic carcinoma are the most common histologic types, accounting for 33 and 24 percent of cases, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/76\">",
"     76",
"    </a>",
"    ]. Key features in identifying malignant potential in any salivary gland tumor include invasion of adjacent tissue, perineural or",
"    <span class=\"nowrap\">",
"     lymphatic/vascular",
"    </span>",
"    invasion, increased mitotic activity, and cytologic atypia. The three most common malignant salivary gland tumors are discussed here; the rarer malignancies are reviewed elsewhere [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Mucoepidermoid carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mucoepidermoid carcinoma is the most common malignant SGT in adults and children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/76\">",
"     76",
"    </a>",
"    ]. It consists of a mixture of mucin-producing columnar cells, epidermoid (squamous) cells, and polygonal intermediate cells (",
"    <a class=\"graphic graphic_picture graphicRef60211 \" href=\"UTD.htm?32/19/33078\">",
"     picture 22",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    While tumor stage is the most important prognostic feature for mucoepidermoid carcinoma, histologic grading has prognostic significance. The WHO system assigns points to individual histologic features, which contribute to a final score (",
"    <a class=\"graphic graphic_table graphicRef67804 \" href=\"UTD.htm?10/7/10363\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/81\">",
"     81",
"    </a>",
"    ]. The Armed Forces Institute of Pathology system separates patients into three groups; low grade tumors have scores of 0 to 4 points, intermediate grade tumors 5 to 6 points, and high grade mucoepidermoid carcinoma &ge;7 points. In one study, after at least three years of follow-up, there were no locoregional recurrences or distant metastases among patients with low grade MEC [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/82\">",
"     82",
"    </a>",
"    ]. In contrast, 45 percent of patients with high grade and 67 percent with intermediate grade MEC experienced a recurrence or metastases.",
"   </p>",
"   <p>",
"    In addition to tumor grade, age greater than 40 years, tumor fixation and T and N stages were individually found to be independent prognostic features [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/83\">",
"     83",
"    </a>",
"    ]. Most reports show that mucoepidermoid carcinomas arising in the submandibular gland tend to behave aggressively, regardless of grade. In contrast, mucoepidermoid carcinoma arising in the pediatric age group tends to have a favorable prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A translocation involving (11;19)(q21;p13), which produces a unique fusion product, MECT1-MAML2, occurs commonly in mucoepidermoid carcinoma and may be prognostically favorable [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/85,86\">",
"     85,86",
"    </a>",
"    ]. Epidermal growth factor receptor (EGFR) is overexpressed in about two-thirds of cases, in contrast to human epidermal growth factor receptor 2 (HER2), which is expressed in less than 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/87\">",
"     87",
"    </a>",
"    ]. Herceptin, a monoclonal antibody that targets HER2 overexpressing cells, appears to have low activity, even among HER2+ cases of SGT [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/88\">",
"     88",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=see_link&amp;anchor=H2#H2\">",
"     \"Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging\", section on 'Epidemiology and risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Adenoid cystic carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adenoid cystic carcinoma was previously considered to be the most common form of malignant minor salivary gland tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/76\">",
"     76",
"    </a>",
"    ]. Many of these cases have been subsequently reclassified as polymorphous low-grade adenocarcinoma (PLGA). Adenoid cystic carcinoma is now considered the second most common malignant salivary gland tumor overall, and depending on the series, adenoid cystic carcinoma ranks first or second among malignant minor salivary gland tumors.",
"   </p>",
"   <p>",
"    Adenoid cystic carcinoma can arise from either the major or minor salivary glands, but less commonly arises in the parotid gland. The tumor is locally aggressive, with local recurrences often arising after many years.",
"   </p>",
"   <p>",
"    Three basic growth patterns are commonly seen: tubular, cribriform (",
"    <a class=\"graphic graphic_picture graphicRef67445 \" href=\"UTD.htm?18/46/19176\">",
"     picture 23",
"    </a>",
"    ), and solid. These patterns form the basis for the traditional grading system (tubular = grade 1, cribriform = grade 2, and solid = grade 3). The biologic aggressiveness of adenoid cystic carcinoma correlates with the amount of the solid component within the tumor. The solid areas generally contain cells with larger, more pleomorphic nuclei, increased mitotic activity, and often, foci of necrosis. These findings are reflected in a revised grading scheme: grade 1 tumors are composed entirely of tubules or cribriform areas, while the presence of a solid component defines higher-grade tumors. A 30 percent solid component serves as the breakpoint between grade 2 and 3 tumors.",
"   </p>",
"   <p>",
"    In a study of 129 cases, clinical stage, solid growth pattern, and p53 expression were found by multivariate analysis to be the most important prognostic features in head and neck adenoid cystic carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/89\">",
"     89",
"    </a>",
"    ]. Increased proliferative activity has also been reported as an adverse prognostic factor [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/90,91\">",
"     90,91",
"    </a>",
"    ]. ACC has a marked propensity for perineural invasion. As with other tumors that commonly invade perineural spaces, neural cell adhesion molecule (NCAM), nerve growth factor (NGF) and its receptor, TrkA, are commonly expressed in adenoid cystic carcinoma, and may provide the molecular basis underlying its behavior [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/92,93\">",
"     92,93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Polymorphous low-grade adenocarcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most series, polymorphous low-grade adenocarcinoma is the third most common tumor of the minor salivary glands, behind MEC and ACC. PLGA is an infiltrative tumor composed of uniform cells with multiple growth patterns within the same tumor. These tumors often resemble adenoid cystic carcinoma and share a tendency to invade perineural spaces (",
"    <a class=\"graphic graphic_picture graphicRef56794 \" href=\"UTD.htm?28/2/28711\">",
"     picture 24",
"    </a>",
"    ). Immunohistochemical studies may be useful in differentiating these tumors. In contrast to polymorphous low-grade adenocarcinoma, adenoid cystic carcinoma often shows strong staining of luminal cells for c-kit and shows diffuse expression of smooth muscle actin in its myoepithelial component [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/94,95\">",
"     94,95",
"    </a>",
"    ]. This distinction is clinically important since polymorphous low-grade adenocarcinoma may be treated with a more conservative surgical approach than is required for ACC [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/96-98\">",
"     96-98",
"    </a>",
"    ]. However, adequate surgical excision is important to minimize local recurrences, which have the potential for histologic progression [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/99\">",
"     99",
"    </a>",
"    ]. Some authors recommend postoperative radiation to decrease local recurrences [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     MESENCHYMAL TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Head and neck sarcomas are relatively rare, accounting for 2 percent of all head and neck malignancies. This topic is discussed in detail elsewhere; however, two tumors specific for or with special characteristics in the head and neck region are discussed here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/50/34602?source=see_link\">",
"     \"Head and neck sarcomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Juvenile nasopharyngeal angiofibromas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Juvenile nasopharyngeal angiofibromas (JNA) are rare tumors of adolescent males, generally presenting with epistaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/101\">",
"     101",
"    </a>",
"    ]. The lesion shows thin-walled vessels, devoid of smooth muscle, often arranged in a stag horn pattern, and set in a fibrous to myxoid stroma (",
"    <a class=\"graphic graphic_picture graphicRef76943 \" href=\"UTD.htm?17/24/17797\">",
"     picture 25",
"    </a>",
"    ). The histogenesis of these tumors remains unclear.",
"   </p>",
"   <p>",
"    Some cases appear to be manifestations of the familial adenomatous polyposis syndrome with abnormal nuclear localization of beta-catenin described in stromal cells of the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/101,102\">",
"     101,102",
"    </a>",
"    ]. A number of growth factors and receptors have been identified in stromal cells of JNA including VEGF, VEGFR2, TGFbeta1, and IGFII [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/101,102\">",
"     101,102",
"    </a>",
"    ]. These tumors were previously thought to express androgen receptors but not estrogen receptors (ER). One report has identified strong expression of the more recently described ER isoform, ER-beta [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/103\">",
"     103",
"    </a>",
"    ]. It is hoped that these findings may allow the design of new therapies using agents targeting VEGFR or ER.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Sinonasal hemangiopericytomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sinonasal hemangiopericytomas (HPC) enter the histologic differential diagnosis of angiofibroma. In contrast to angiofibroma, hemangiopericytomas are tumors of middle age and show no sex predominance. They typically are circumscribed lesions composed of packed spindle cells arranged in short fascicles with a prominent staghorn vascular arrangement. The vessels are of various thicknesses, but generally lack smooth muscle and often have a perivascular cuff of hyalinized tissue (",
"    <a class=\"graphic graphic_picture graphicRef56094 \" href=\"UTD.htm?24/62/25575\">",
"     picture 26",
"    </a>",
"    ). Immunohistochemical studies demonstrate reactivity of the spindle cells for actin and vimentin, but not for CD31 or CD34. Although generally a low-grade tumor, they frequently recur locally and occasionally metastasize [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/104\">",
"     104",
"    </a>",
"    ]. These tumors appear to be distinct from HPCs arising elsewhere in the body. In contrast to HPCs elsewhere, sino-nasal tumors stain with antibodies to the lymphatic endothelial marker, D2-40 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/4/12362/abstract/105\">",
"     105",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cancer of the head and neck refers to a collection of cancers, predominantly squamous cell carcinoma, arising from a variety of sites and grouped together under this designation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Several noninvasive lesions may develop within the squamous mucosa that lines the structures of the head and neck. Transformation of premalignant lesions is thought to progress in a multistep fashion from hyperplasia and dysplasia to in situ and invasive carcinoma. Histopathology is limited in its ability to predict malignant transformation and thus, close clinical follow-up of premalignant lesions is suggested. &nbsp;(See",
"      <a class=\"local\" href=\"#H2\">",
"       'Noninvasive squamous epithelial lesions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Squamous hyperplasia and dysplasia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Squamous cell carcinoma (SCC) accounts for up to 90 percent of all malignant tumors of the head and neck. These tumors are graded as well-, moderately-, or poorly-differentiated based upon how closely they resemble normal squamous epithelium. Though the size of the cancer and the presence or absence of nodal metastasis currently remain the major prognostic determinants in head and neck squamous cell carcinoma, there is much interest in the role of molecular prognostic factors. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Invasive squamous cell carcinoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Verrucous, basaloid, spindle cell, and nasopharyngeal carcinoma have distinct architectural and histologic features and well-documented differences in behavior. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Invasive squamous cell carcinoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other mucosal epithelial tumors include Scheiderian papillomas and sinonasal undifferentiated carcinoma. Schneiderian papillomas, consisting of fungiform, inverted papillomas, and oncocytic Schneiderian papillomas, most often arise from the ectodermally derived mucosa of the nasal cavity and sinuses (Schneiderian epithelium). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Other mucosal epithelial tumors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most head and neck adenocarcinomas arise from salivary glands or from the sinonasal tract and range from low-grade to aggressive in behavior. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Sinonasal adenocarcinomas'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Salivary gland tumors (SGT) vary considerably in their histologic patterns and behavior. Most SGTs are composed of more than one cell type, with analogies to the composition of normal salivary glands. Mucoepidermoid carcinoma and polymorphous low grade adenocarcinoma are the most common histologic types of malignant SGTs. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Salivary gland tumors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Head and neck sarcomas are relatively rare. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Mesenchymal tumors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Biopsy Interpretation of the Upper Aerodigestive Tract and Ear, Mills SE, Stelow EB (Eds), Lippincott Williams &amp; Wilkins, 2007.",
"    </li>",
"    <li>",
"     Pathology of the Head and Neck, Cadesa A, Slootweg PJ (Eds), Springer-Verlag LLC, New York 2006.",
"    </li>",
"    <li>",
"     Head and Neck Pathology: A Volume in Foundations in Diagnostic Pathology Series, Goldblum JR (Ed), Elsevier Health Sciences, 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/4\">",
"      Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med 2007; 36:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/5\">",
"      Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 2006; 42:461.",
"     </a>",
"    </li>",
"    <li>",
"     World Heath Organization Classification of Tumors: Pathology and Genetics: Head and Neck Tumors, Barnes L, Everson JW, Reichart P, Sidransky D (Eds), WHO Press, Switzerland 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/7\">",
"      Kujan O, Khattab A, Oliver RJ, et al. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation. Oral Oncol 2007; 43:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/8\">",
"      Kujan O, Oliver RJ, Khattab A, et al. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 2006; 42:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/9\">",
"      Hsue SS, Wang WC, Chen CH, et al. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med 2007; 36:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/10\">",
"      Noutomi Y, Oga A, Uchida K, et al. Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways. J Pathol 2006; 210:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/11\">",
"      Hassan NM, Hamada J, Murai T, et al. Aberrant expression of HOX genes in oral dysplasia and squamous cell carcinoma tissues. Oncol Res 2006; 16:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/12\">",
"      Shah NG, Trivedi TI, Tankshali RA, et al. Molecular alterations in oral carcinogenesis: significant risk predictors in malignant transformation and tumor progression. Int J Biol Markers 2007; 22:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/13\">",
"      Burzlaff JB, Bohrer PL, Paiva RL, et al. Exposure to alcohol or tobacco affects the pattern of maturation in oral mucosal cells: a cytohistological study. Cytopathology 2007; 18:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/14\">",
"      Yuen AP, Ng RW, Lam PK, Ho A. Preoperative measurement of tumor thickness of oral tongue carcinoma with intraoral ultrasonography. Head Neck 2008; 30:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/15\">",
"      Warburton G, Nikitakis NG, Roberson P, et al. Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg 2007; 65:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/16\">",
"      Salesiotis AN, Cullen KJ. Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging. Curr Opin Oncol 2000; 12:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/17\">",
"      Valente G, Mamo C, Bena A, et al. Prognostic significance of microvessel density and vascular endothelial growth factor expression in sinonasal carcinomas. Hum Pathol 2006; 37:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/18\">",
"      M&eacute;ndez E, Fan W, Choi P, et al. Tumor-specific genetic expression profile of metastatic oral squamous cell carcinoma. Head Neck 2007; 29:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/19\">",
"      Goldenberg D, Harden S, Masayesva BG, et al. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg 2004; 130:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/20\">",
"      Longatto Filho A, Oliveira TG, Pinheiro C, et al. How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis? World J Surg Oncol 2007; 5:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/21\">",
"      Smith BD, Smith GL, Carter D, et al. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 2000; 18:2046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/22\">",
"      Imanishi Y, Fujii M, Tokumaru Y, et al. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol 2000; 31:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/23\">",
"      Poeta ML, Manola J, Goldwasser MA, et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 2007; 357:2552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/24\">",
"      O'Regan EM, Toner ME, Smyth PC, et al. Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients. Head Neck 2006; 28:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/25\">",
"      Addante RR, McKenna SJ. Verrucous carcinoma. Oral Maxillofac Surg Clin North Am 2006; 18:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/26\">",
"      Szentirmay Z, P&oacute;lus K, Tam&aacute;s L, et al. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations. Cancer Metastasis Rev 2005; 24:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/27\">",
"      Adegboyega PA, Boromound N, Freeman DH. Diagnostic utility of cell cycle and apoptosis regulatory proteins in verrucous squamous carcinoma. Appl Immunohistochem Mol Morphol 2005; 13:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/28\">",
"      Orvidas LJ, Olsen KD, Lewis JE, Suman VJ. Verrucous carcinoma of the larynx: a review of 53 patients. Head Neck 1998; 20:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/29\">",
"      Impola U, Uitto VJ, Hietanen J, et al. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 2004; 202:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/30\">",
"      Huang SH, Lockwood G, Irish J, et al. Truths and myths about radiotherapy for verrucous carcinoma of larynx. Int J Radiat Oncol Biol Phys 2009; 73:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/31\">",
"      Koch BB, Trask DK, Hoffman HT, et al. National survey of head and neck verrucous carcinoma: patterns of presentation, care, and outcome. Cancer 2001; 92:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/32\">",
"      Salesiotis A, Soong R, Diasio RB, et al. Capecitabine induces rapid, sustained response in two patients with extensive oral verrucous carcinoma. Clin Cancer Res 2003; 9:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/33\">",
"      Chen HM, Chen CT, Yang H, et al. Successful treatment of an extensive verrucous carcinoma with topical 5-aminolevulinic acid-mediated photodynamic therapy. J Oral Pathol Med 2005; 34:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/34\">",
"      Wu CF, Chen CM, Shen YS, et al. Effective eradication of oral verrucous carcinoma with continuous intraarterial infusion chemotherapy. Head Neck 2008; 30:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/35\">",
"      Morton TH, Cabay RJ, Epstein JB. Proliferative verrucous leukoplakia and its progression to oral carcinoma: report of three cases. J Oral Pathol Med 2007; 36:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/36\">",
"      Bagan JV, Jimenez Y, Sanchis JM, et al. Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma. J Oral Pathol Med 2003; 32:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/37\">",
"      Sakurai K, Urade M, Takahashi Y, et al. Increased expression of c-erbB-3 protein and proliferating cell nuclear antigen during development of verrucous carcinoma of the oral mucosa. Cancer 2000; 89:2597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/38\">",
"      Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/39\">",
"      Thariat J, Ahamad A, El-Naggar AK, et al. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study. Cancer 2008; 112:2698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/40\">",
"      Fritsch VA, Lentsch EJ. Basaloid squamous cell carcinoma of the oropharynx: an analysis of 650 cases. Otolaryngol Head Neck Surg 2013; 148:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/41\">",
"      Gupta R, Singh S, Hedau S, et al. Spindle cell carcinoma of head and neck: an immunohistochemical and molecular approach to its pathogenesis. J Clin Pathol 2007; 60:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/42\">",
"      Spector ME, Wilson KF, Light E, et al. Clinical and pathologic predictors of recurrence and survival in spindle cell squamous cell carcinoma. Otolaryngol Head Neck Surg 2011; 145:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/43\">",
"      Minami SB, Shinden S, Yamashita T. Spindle cell carcinoma of the palatine tonsil: report of a diagnostic pitfall and literature review. Am J Otolaryngol 2008; 29:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/44\">",
"      Olsen KD, Lewis JE, Suman VJ. Spindle cell carcinoma of the larynx and hypopharynx. Otolaryngol Head Neck Surg 1997; 116:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/45\">",
"      Fan SQ, Ma J, Zhou J, et al. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum Pathol 2006; 37:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/46\">",
"      Lo AK, Lo KW, Tsao SW, et al. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 2006; 8:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/47\">",
"      Zeng ZY, Zhou YH, Zhang WL, et al. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 2007; 38:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/48\">",
"      Peng D, Ren CP, Yi HM, et al. Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim Biophys Sin (Shanghai) 2006; 38:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/49\">",
"      Lawson W, Patel ZM. The evolution of management for inverted papilloma: an analysis of 200 cases. Otolaryngol Head Neck Surg 2009; 140:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/50\">",
"      Batsakis JG, Suarez P. Schneiderian papillomas and carcinomas: a review. Adv Anat Pathol 2001; 8:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/51\">",
"      Kaufman MR, Brandwein MS, Lawson W. Sinonasal papillomas: clinicopathologic review of 40 patients with inverted and oncocytic schneiderian papillomas. Laryngoscope 2002; 112:1372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/52\">",
"      Mumbuc S, Karakok M, Baglam T, et al. Immunohistochemical analysis of PCNA, Ki67 and p53 in nasal polyposis and sinonasal inverted papillomas. J Int Med Res 2007; 35:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/53\">",
"      Weiner JS, Sherris D, Kasperbauer J, et al. Relationship of human papillomavirus to Schneiderian papillomas. Laryngoscope 1999; 109:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/54\">",
"      Katori H, Nozawa A, Tsukuda M. Histopathological parameters of recurrence and malignant transformation in sinonasal inverted papilloma. Acta Otolaryngol 2006; 126:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/55\">",
"      Busquets JM, Hwang PH. Endoscopic resection of sinonasal inverted papilloma: a meta-analysis. Otolaryngol Head Neck Surg 2006; 134:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/56\">",
"      Woodworth BA, Bhargave GA, Palmer JN, et al. Clinical outcomes of endoscopic and endoscopic-assisted resection of inverted papillomas: a 15-year experience. Am J Rhinol 2007; 21:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/57\">",
"      Cerilli LA, Holst VA, Brandwein MS, et al. Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association. Am J Surg Pathol 2001; 25:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/58\">",
"      Ejaz A, Wenig BM. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis. Adv Anat Pathol 2005; 12:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/59\">",
"      Luna MA. Sinonasal tubulopapillary low-grade adenocarcinoma: a specific diagnosis or just another seromucous adenocarcinoma? Adv Anat Pathol 2005; 12:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/60\">",
"      Resto VA, Krane JF, Faquin WC, Lin DT. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin. Ann Otol Rhinol Laryngol 2006; 115:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/61\">",
"      Kennedy MT, Jordan RC, Berean KW, Perez-Ordo&ntilde;ez B. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol 2004; 57:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/62\">",
"      Ortiz-Rey JA, Alvarez C, San Miguel P, et al. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma. Appl Immunohistochem Mol Morphol 2005; 13:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/63\">",
"      Bimbi G, Saraceno MS, Riccio S, et al. Adenocarcinoma of ethmoid sinus: an occupational disease. Acta Otorhinolaryngol Ital 2004; 24:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/64\">",
"      Orvidas LJ, Lewis JE, Weaver AL, et al. Adenocarcinoma of the nose and paranasal sinuses: a retrospective study of diagnosis, histologic characteristics, and outcomes in 24 patients. Head Neck 2005; 27:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/65\">",
"      Yom SS, Rashid A, Rosenthal DI, et al. Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance. Mod Pathol 2005; 18:315.",
"     </a>",
"    </li>",
"    <li>",
"     Mills SE, Gaffey MJ, Frierson HF JR. Tumors of the upper respiratory tract and ear, Atlas of Tumor Pathology - 3rd Series (Ed), Armed Forces Institute of Pathology, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/67\">",
"      Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 2007; 133:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/68\">",
"      Diaz EM Jr, Johnigan RH 3rd, Pero C, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck 2005; 27:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/69\">",
"      El-Naggar AK, Callender D, Coombes MM, et al. Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model? Genes Chromosomes Cancer 2000; 27:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/70\">",
"      Czader M, Eberhart CG, Bhatti N, et al. Metastasizing mixed tumor of the parotid: initial presentation as a solitary kidney tumor and ultimate carcinomatous transformation at the primary site. Am J Surg Pathol 2000; 24:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/71\">",
"      Kunimura T. Noninvasive carcinoma ex pleomorphic adenoma of the parotid gland. Otolaryngol Head Neck Surg 2007; 137:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/72\">",
"      Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck 2001; 23:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/73\">",
"      Freitas LL, Ara&uacute;jo VC, Martins MT, et al. Biomarker analysis in carcinoma ex pleomorphic adenoma at an early phase of carcinomatous transformation. Int J Surg Pathol 2005; 13:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/74\">",
"      Ihrler S, Weiler C, Hirschmann A, et al. Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53. Histopathology 2007; 51:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/75\">",
"      Zb&auml;ren P, Zb&auml;ren S, Caversaccio MD, Stauffer E. Carcinoma ex pleomorphic adenoma: diagnostic difficulty and outcome. Otolaryngol Head Neck Surg 2008; 138:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/76\">",
"      Jones AV, Craig GT, Speight PM, Franklin CD. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol 2008; 44:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/77\">",
"      Ansari MH. Salivary gland tumors in an Iranian population: a retrospective study of 130 cases. J Oral Maxillofac Surg 2007; 65:2187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/78\">",
"      Wang D, Li Y, He H, et al. Intraoral minor salivary gland tumors in a Chinese population: a retrospective study on 737 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/79\">",
"      Pires FR, Pringle GA, de Almeida OP, Chen SY. Intra-oral minor salivary gland tumors: a clinicopathological study of 546 cases. Oral Oncol 2007; 43:463.",
"     </a>",
"    </li>",
"    <li>",
"     Tumours of the Salivary Glands. In: Pathology and Genetics of Head and Neck Tumours, Barnes L, Eveson JW, Reichart P, Sidransky D.  (Eds), World Health Organization, Lyon 2005. p.209.",
"    </li>",
"    <li>",
"     World Heath Organization Classification of Tumors: Pathology and Genetics: Head and Neck Tumors, Barnes L, Everson JW, Reichart P, Sidransky D (Eds), WHO Press, Switzerland 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/82\">",
"      Aro K, Leivo I, M&auml;kitie AA. Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: a single institution's 30-year experience. Laryngoscope 2008; 118:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/83\">",
"      Pires FR, de Almeida OP, de Ara&uacute;jo VC, Kowalski LP. Prognostic factors in head and neck mucoepidermoid carcinoma. Arch Otolaryngol Head Neck Surg 2004; 130:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/84\">",
"      V&eacute;drine PO, Coffinet L, Temam S, et al. Mucoepidermoid carcinoma of salivary glands in the pediatric age group: 18 clinical cases, including 11 second malignant neoplasms. Head Neck 2006; 28:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/85\">",
"      Fehr A, R&ouml;ser K, Heidorn K, et al. A new type of MAML2 fusion in mucoepidermoid carcinoma. Genes Chromosomes Cancer 2008; 47:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/86\">",
"      Bell D, Luna MA, Weber RS, et al. CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: evidence for a common genetic association. Genes Chromosomes Cancer 2008; 47:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/87\">",
"      Shang J, Shui Y, Sheng L, et al. Epidermal growth factor receptor and human epidermal growth receptor 2 expression in parotid mucoepidermoid carcinoma: possible implications for targeted therapy. Oncol Rep 2008; 19:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/88\">",
"      Haddad R, Colevas AD, Krane JF, et al. Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study. Oral Oncol 2003; 39:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/89\">",
"      da Cruz Perez DE, de Abreu Alves F, Nobuko Nishimoto I, et al. Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol 2006; 42:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/90\">",
"      Norberg-Spaak L, Dardick I, Ledin T. Adenoid cystic carcinoma: use of cell proliferation, BCL-2 expression, histologic grade, and clinical stage as predictors of clinical outcome. Head Neck 2000; 22:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/91\">",
"      Lima RA, Tavares MR, Dias FL, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg 2005; 133:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/92\">",
"      Wang L, Sun M, Jiang Y, et al. Nerve growth factor and tyrosine kinase A in human salivary adenoid cystic carcinoma: expression patterns and effects on in vitro invasive behavior. J Oral Maxillofac Surg 2006; 64:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/93\">",
"      Shang J, Sheng L, Wang K, et al. Expression of neural cell adhesion molecule in salivary adenoid cystic carcinoma and its correlation with perineural invasion. Oncol Rep 2007; 18:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/94\">",
"      Beltran D, Faquin WC, Gallagher G, August M. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. J Oral Maxillofac Surg 2006; 64:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/95\">",
"      Prasad ML, Barbacioru CC, Rawal YB, et al. Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Mod Pathol 2008; 21:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/96\">",
"      Paleri V, Robinson M, Bradley P. Polymorphous low-grade adenocarcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2008; 16:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/97\">",
"      Evans HL, Luna MA. Polymorphous low-grade adenocarcinoma: a study of 40 cases with long-term follow up and an evaluation of the importance of papillary areas. Am J Surg Pathol 2000; 24:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/98\">",
"      Pogodzinski MS, Sabri AN, Lewis JE, Olsen KD. Retrospective study and review of polymorphous low-grade adenocarcinoma. Laryngoscope 2006; 116:2145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/99\">",
"      Seethala RR, Johnson JT, Barnes EL, Myers EN. Polymorphous low-grade adenocarcinoma: the University of Pittsburgh experience. Arch Otolaryngol Head Neck Surg 2010; 136:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/100\">",
"      Uemaetomari I, Tabuchi K, Tobita T, et al. The importance of postoperative radiotherapy against polymorphous low-grade adenocarcinoma of the parotid gland: case report and review of the literature. Tohoku J Exp Med 2007; 211:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/101\">",
"      Coutinho-Camillo CM, Brentani MM, Nagai MA. Genetic alterations in juvenile nasopharyngeal angiofibromas. Head Neck 2008; 30:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/102\">",
"      Ponti G, Losi L, Pellacani G, et al. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA). Appl Immunohistochem Mol Morphol 2008; 16:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/103\">",
"      Montag AG, Tretiakova M, Richardson M. Steroid hormone receptor expression in nasopharyngeal angiofibromas. Consistent expression of estrogen receptor beta. Am J Clin Pathol 2006; 125:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/104\">",
"      Thompson LD, Miettinen M, Wenig BM. Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol 2003; 27:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/4/12362/abstract/105\">",
"      Hansen T, Katenkamp K, Katenkamp D. D2-40 staining in sinonasal-type hemangiopericytoma--further evidence of distinction from conventional hemangiopericytoma and solitary fibrous tumor. Virchows Arch 2006; 448:459.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3375 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-956556EC73-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12362=[""].join("\n");
var outline_f12_4_12362=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NONINVASIVE SQUAMOUS EPITHELIAL LESIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SQUAMOUS HYPERPLASIA AND DYSPLASIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Squamous hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Squamous dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INVASIVE SQUAMOUS CELL CARCINOMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Histologic and molecular prognostic factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Verrucous carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Basaloid SCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Spindle cell SCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Nasopharyngeal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      OTHER MUCOSAL EPITHELIAL TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Schneiderian papillomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Sinonasal undifferentiated carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SINONASAL ADENOCARCINOMAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      OLFACTORY NEUROBLASTOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SALIVARY GLAND TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Benign salivary gland tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Pleomorphic adenoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H267154018\">",
"      - Carcinoma ex pleomorphic adenoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Malignant tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Mucoepidermoid carcinoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Adenoid cystic carcinoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Polymorphous low-grade adenocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      MESENCHYMAL TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Juvenile nasopharyngeal angiofibromas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Sinonasal hemangiopericytomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/3375\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/3375|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/46/2790\" title=\"picture 1\">",
"      Well diff squamous CA Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/32/43525\" title=\"picture 2\">",
"      Mod diff squamous CA Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/50/14119\" title=\"picture 3\">",
"      Poorly diff squamous CA Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/25/19856\" title=\"picture 4\">",
"      Verrucous carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/50/31524\" title=\"picture 5\">",
"      Verrucous carcinoma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/44/1731\" title=\"picture 6\">",
"      Verrucous hyperplasia Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/46/3817\" title=\"picture 7\">",
"      Basaloid squamous cancer Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/57/35737\" title=\"picture 8\">",
"      Spindle cell carcinoma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/21/41304\" title=\"picture 9\">",
"      Undiff nasopharyngeal CA Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/59/946\" title=\"picture 10\">",
"      Fungiform papilloma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/5/41047\" title=\"picture 11\">",
"      Inverted papilloma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/31/6645\" title=\"picture 12\">",
"      Schneiderian papilloma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/61/24530\" title=\"picture 13\">",
"      Squamous papilloma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/21/31061\" title=\"picture 14\">",
"      Sinonasal polyp Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/16/3335\" title=\"picture 15\">",
"      Sinonasal undiff CA Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/47/2808\" title=\"picture 16\">",
"      Well diff sinonasal CA Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/42/1702\" title=\"picture 17\">",
"      Intestinal sinonasal CA Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/37/3671\" title=\"picture 18\">",
"      Olfactory neuroblastoma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/21/10584\" title=\"picture 19\">",
"      Warthins tumor Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/33/43543\" title=\"picture 20\">",
"      CA ex pleomorphic adenoma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/14/233\" title=\"picture 21\">",
"      Pleomorphic adenoma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/19/33078\" title=\"picture 22\">",
"      Mucoepidermoid carcinoma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/46/19176\" title=\"picture 23\">",
"      Adenoid cystic carcinoma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/2/28711\" title=\"picture 24\">",
"      Polymorph low gr adenoCA Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/24/17797\" title=\"picture 25\">",
"      Angiofibroma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/62/25575\" title=\"picture 26\">",
"      Hemangiopericytoma Light",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/3375|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/1/7196\" title=\"table 1\">",
"      WHO grade crit oral dysp",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/36/21069\" title=\"table 2\">",
"      WHO class salivary gld tum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/7/10363\" title=\"table 3\">",
"      WHO gr mucoepidermoid carc",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/36/26184?source=related_link\">",
"      Epidemiology, etiology, and diagnosis of nasopharyngeal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/50/34602?source=related_link\">",
"      Head and neck sarcomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34825?source=related_link\">",
"      Head and neck squamous cell carcinogenesis: Molecular and genetic alterations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/46/12008?source=related_link\">",
"      Olfactory neuroblastoma (esthesioneuroblastoma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36537?source=related_link\">",
"      Overview of the diagnosis and staging of head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/44/23241?source=related_link\">",
"      Paranasal sinus cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=related_link\">",
"      Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/41/28313?source=related_link\">",
"      Salivary gland tumors: Treatment of locoregional disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_4_12363="Postictal symptoms";
var content_f12_4_12363=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F59341&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F59341&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common postictal symptoms",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Confusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Depression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficulty talking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Embarrassment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Exhaustion, sleep",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fear",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frustration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Headache",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Loneliness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Memory loss",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nausea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Perceptual alterations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psychosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thirst",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weakness",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12363=[""].join("\n");
var outline_f12_4_12363=null;
var title_f12_4_12364="Clinician response to gender nonconformity";
var content_f12_4_12364=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F86987&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F86987&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Examples of responses to caregiver concerns about gender nonconformity",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Example of question",
"       </td>",
"       <td class=\"subtitle1\">",
"        Poor response",
"       </td>",
"       <td class=\"subtitle1\">",
"        Supportive response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        I am worried about how often my son plays with his sister's dolls. What do you think? Do you think my son may be gay?",
"       </td>",
"       <td>",
"        Playing with dolls is not typical of boys. He may be gay. Maybe I should refer you to a psychiatrist.",
"       </td>",
"       <td>",
"        Tell me more about what sort of play and activities your son enjoys? How do you and the family support and encourage the range of his play? All children experiment with&nbsp;and explore the other gender's toys and play. What is most important is for you to help your child explore his interests.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        My school-age daughter refuses to wear a dress. She is always playing with the neighborhood boys. I think she may be a lesbian. I am worried.",
"       </td>",
"       <td>",
"        Lots of girls hate dresses. But you as the parent can make her wear what you think is appropriate. You need to set better limits on her clothing choices.",
"       </td>",
"       <td>",
"        Tell me more about the conversations you and your daughter have had around wearing dresses, girls' clothing, etc. Why does your daughter refuse? Has she talked about other aspects of being a girl or gender? What would she wear if it was all up to her?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        We found out that my daughter thinks she is a boy trapped in a girl's body from a Facebook post. Can we help her not be a lesbian?",
"       </td>",
"       <td>",
"        Being gay is not so bad anymore. Being gay is more accepted and cool for kids.",
"       </td>",
"       <td>",
"        Let's talk some more and try to understand about her identity and feelings about her gender, versus her feelings, attractions, and possible sexual orientation. Gender and sexual orientation get confusing but they are very different aspects of each person.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        My son is driving his father crazy with the feminine clothes he wears, his long hair, etc. My son and his father fight all the time. I am so worried. What should I do?",
"       </td>",
"       <td>",
"        You should tell your son to get a haircut and wear normal clothing. Being effeminate is only going to&nbsp;get him beat up at school.",
"       </td>",
"       <td>",
"        Why do you think this upsets his dad? Does it upset you? Have you talked to your son about his preference for feminine clothes? Have you asked him how he feels about his dad's reactions and the fighting?",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12364=[""].join("\n");
var outline_f12_4_12364=null;
var title_f12_4_12365="Extra-abdominal causes abdominal pain";
var content_f12_4_12365=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60310&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60310&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Selected extraabdominal causes of acute abdominal pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Cardiac",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Myocardial ischemia and infarction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Myocarditis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Endocarditis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Heart failure",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Thoracic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pneumonitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pleurodynia, Bornholm's disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary embolism and infarction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pneumothorax",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Empyema",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Esophagitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Esophageal spasm",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Esophageal rupture (Boerhaave's syndrome)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Neurologic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Radiculitis: spinal cord or peripheral nerve tumors, degenerative arthritis of spine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Abdominal epilepsy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tabes dorsalis (tertiary syphilis)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Metabolic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Uremia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Diabetes mellitus (ketoacidosis)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Porphyria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute adrenal insufficiency",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hyperlipidemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hyperparathyroidism",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Hematologic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sickle cell anemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hemolytic anemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Henoch-Sch&ouml;nlein purpura",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute leukemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Toxins",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hypersensitivity reactions: insect bites, reptile venoms",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Heavy metals and corrosives (eg, lead or iron)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Infections",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Herpes zoster",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Osteomyelitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Typhoid fever",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_left\">",
"            Miscellaneous",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Muscular contusion, hematoma, or tumor",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Narcotic withdrawal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Familial Mediterranean fever",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Psychiatric disorders",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Heat stroke",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Glasgow RE, Mulvihill SJ. Abdominal pain, including the acute abdomen. In: Gastrointestinal and Liver Disease, Feldman M, Scharschmidt BF, Sleisenger MH (Eds). WB Saunders, Philadelphia 1998, p.80. Copyright &copy; 1998 W.B. Saunders.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12365=[""].join("\n");
var outline_f12_4_12365=null;
var title_f12_4_12366="Anticoagulation algorithm in HD";
var content_f12_4_12366=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F53330&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F53330&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 480px\">",
"   <div class=\"ttl\">",
"    Guidelines for anticoagulation in dialysis patients at high risk for bleeding",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 460px; height: 204px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Guidelines for treatment of patients with renal failure requiring dialysis but at high risk for bleeding.",
"    <div class=\"footnotes\">",
"     CAVH/D: continuous arteriovenous hemofiltration or hemodialysis; RCA: regional citrate administration.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12366=[""].join("\n");
var outline_f12_4_12366=null;
var title_f12_4_12367="IVP in obstruction II";
var content_f12_4_12367=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F73212&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F73212&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intravenous pyelogram showing ureterovesical junction obstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 254px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pelvic view of intravenous pyelogram showing bilateral ureterovesical junction obstruction (arrows) with proximal ureteral dilatation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Rose BD, Pathophysiology of Renal Disease, 2d ed, McGraw-Hill, New York, 1987.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_4_12367=[""].join("\n");
var outline_f12_4_12367=null;
